var title_f39_26_40352="C diphtheriae photomicrograph";
var content_f39_26_40352=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Photomicrograph of Corynebacterium diphtheriae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photomicrograph depicts numerous Gram-positive asporogenous, rod-shaped, Corynebacterium diphtheriae bacteria.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention Public Health Image Library. Available at: file://phil.cdc.gov/phil/home.asp.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40352=[""].join("\n");
var outline_f39_26_40352=null;
var title_f39_26_40353="LS SCC 2";
var content_f39_26_40353=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichen sclerosus (LS) and squamous cell cancer (SCC)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 310px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annular plaque of LS around the vulva with periclitoral thickening and painful erosions on the left side. Biopsy site visible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD&nbsp;and Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40353=[""].join("\n");
var outline_f39_26_40353=null;
var title_f39_26_40354="Unstable comminuted distal phalanx shaft fracture";
var content_f39_26_40354=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F75518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F75518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Unstable comminuted distal phalanx shaft fracture with nail bed laceration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shaft fractures are usually stable and can be managed with a simple splint that immobilizes the distal interphalangeal joint (DIPJ) but leaves the proximal interphalangeal joint (PIPJ) free. However, comminution of the distal phalanx shaft can render the fracture unstable. In such cases, open reduction with internal fixation (ORIF) is needed. This figure shows a comminuted unstable distal phalanx fracture requiring ORIF.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40354=[""].join("\n");
var outline_f39_26_40354=null;
var title_f39_26_40355="Histologic appearance of meningioma grades I-III";
var content_f39_26_40355=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60534&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60534&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Histologic appearance of meningioma, WHO grades I-III",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 151px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: transitional meningioma (grade I) showing characteristic cellular whorls; intranuclear pseudo-inclusions are visible in some cells. Middle panel: Chordoid meningioma (grade II) with cohesive epithelial-like cords of cells; small foci of more typical arachnoidal differentiation are found in most of these tumors. Right panel: anaplastic meningioma (grade III) consisting of pleiomorphic arachnoidal cells with a high mitotic rate; foci of necrosis are widely distributed throughout most anaplastic meningiomas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Whittle, IR, Smith, C, Navoo, P, Collie, D. Meningiomas. The Lancet 2004; 363:1536. Copyright &copy;2004 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40355=[""].join("\n");
var outline_f39_26_40355=null;
var title_f39_26_40356="Saphenous cutdown site and immobilization";
var content_f39_26_40356=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F71783&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F71783&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Saphenous cutdown site",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A saphenous cutdown is best performed where the vein courses anterior to the medial malleolus of the tibia. An incision (about 2 cm in length) through the skin is made perpendicular to the long axis of the vein.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40356=[""].join("\n");
var outline_f39_26_40356=null;
var title_f39_26_40357="Subconjunctival dirofilariasis";
var content_f39_26_40357=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subconjunctival dirofilariasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A female worm of",
"    <em>",
"     D. tenuis",
"    </em>",
"    (arrow) in the conjunctiva of the left eye of a patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Koneman EW, Sutton DA, Fothergill AW, et al. LWW's Organism Central. Philadelphia: Lippincott Williams &amp; Wilkins, 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40357=[""].join("\n");
var outline_f39_26_40357=null;
var title_f39_26_40358="Cutaneous squamous cell carcinoma - dorsal hand";
var content_f39_26_40358=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F64981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F64981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous, scaly papule is present on the dorsal hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40358=[""].join("\n");
var outline_f39_26_40358=null;
var title_f39_26_40359="Ruptured Meckels diverticulum on CT";
var content_f39_26_40359=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 617px\">",
"   <div class=\"ttl\">",
"    Ruptured Meckel&rsquo;s diverticulum on CT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 597px; height: 436px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 21-year-old male had a surgically proven ruptured Meckel's diverticulum. The nonspecific CT findings include induration of the omentum (arrow) with bubbles of free air noted in the subumbilical region (arrowhead) suggesting a ruptured viscus. A thick walled bowel loop with contrast in the lumen noted in image C (short arrow) was thought to represent a focal region of abnormal small bowel, and likely represented the ruptured Meckel's diverticulum. Free fluid is noted in the cul de sac (dashed arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40359=[""].join("\n");
var outline_f39_26_40359=null;
var title_f39_26_40360="Medical therapy to prevent complications after coronary artery bypass graft surgery";
var content_f39_26_40360=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Medical therapy to prevent complications after coronary artery bypass graft surgery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Sary Aranki, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Julian M Aroesty, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Gabriel S Aldea, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Edward Verrier, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Guy S Reeder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40360/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/26/40360/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of coronary heart disease (CHD) has evolved significantly over the past several years due in part to improvement in both surgical and percutaneous revascularization techniques. The majority of patients with chronic stable angina are still treated with medical therapy; however, revascularization with either coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention (PCI) should be considered in several subgroups. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/51/9018?source=see_link\">",
"     \"Medical therapy versus revascularization in the management of stable angina pectoris\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The medical therapies that can minimize the short-term, particularly perioperative complications that can occur following conventional CABG (using cardiopulmonary bypass) will be reviewed here. A general discussion of the early complications of CABG is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35226?source=see_link\">",
"     \"Early noncardiac complications of coronary artery bypass graft surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ASPIRIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    should be administered to all patients without a contraindication who have cardiovascular disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37066?source=see_link\">",
"     \"Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With respect to efficacy in patients undergoing CABG, a systematic review from the Antiplatelet Trialists' Collaboration concluded that antiplatelet therapy, particularly if given early, was associated with improved graft patency at an average of one year after surgery (pooled odds reduction for graft closure of 44 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/1\">",
"     1",
"    </a>",
"    ]. This benefit was similar with low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    (75 to 325",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    as with higher and more gastrotoxic doses. Antacids and proton pump inhibitors are commonly given in the perioperative period to further attenuate this risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Preoperative aspirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to give",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    prior to CABG needs to balance concerns of excess bleeding with potential benefits such as reduced graft patency or improved survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Randomized trials published in 1990 and 1991 found that preoperative",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy increased the need for reoperation for postoperative bleeding (6.6 versus 1.7 percent and 6.3 versus 2.4 percent in two trials) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. However, later observational studies found no increase in bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35226?source=see_link&amp;anchor=H8#H8\">",
"     \"Early noncardiac complications of coronary artery bypass graft surgery\", section on 'Bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The potential benefit of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    with regard to vein graft occlusion was addressed in a randomized trial that compared the efficacy of aspirin (325 mg) or placebo given the night before surgery, with postoperative aspirin being given to all patients beginning six hours after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/2\">",
"     2",
"    </a>",
"    ]. There was no difference in saphenous vein graft occlusion between the two groups at an average of eight days after surgery (7.4 versus 7.8 percent), but there was a nonsignificant trend toward a lower rate of occlusion of internal thoracic artery grafts (0 versus 2.4 percent) for the group receiving aspirin preoperatively.",
"   </p>",
"   <p>",
"    Observational data suggest that preoperative",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    may reduce in-hospital mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/4,5\">",
"     4,5",
"    </a>",
"    ], an effect that may reflect protection against perioperative coronary and cerebrovascular events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/6\">",
"     6",
"    </a>",
"    ]. The following two observational studies illustrate the potential magnitude of this benefit:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study of 1636 consecutive patients undergoing a first CABG surgery, 80 percent of patients had taken",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      within the five days before surgery, and all patients received postoperative aspirin six hours after surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/4\">",
"       4",
"      </a>",
"      ]. Preoperative aspirin was associated with a significant reduction in postoperative in-hospital mortality (1.7 versus 4.4 percent, adjusted odds ratio 0.34, 95% CI 0.15-0.75).",
"     </li>",
"     <li>",
"      A significant relative reduction in in-hospital mortality for patients treated with preoperative",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      was noted in a case-control study of more than 5000 patients undergoing isolated CABG (multivariate adjusted odds ratio 0.55, 95% CI 0.31-0.98) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/5\">",
"       5",
"      </a>",
"      ]. Discontinuing aspirin use prior to CABG may increase in-hospital mortality and ischemic complications [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The issue of optimal timing of discontinuing preoperative",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    was addressed in a study of over 4143 patients undergoing CABG at the Cleveland Clinic, some of whom had aspirin discontinued six or more days before surgery and some within five days of surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/8\">",
"     8",
"    </a>",
"    ]. Among 1519 well-matched pairs of patients (after propensity score analysis), there was no significant difference between those with early and late aspirin discontinuation with regard to the composite outcome of in-hospital mortality, myocardial infarction, and stroke (1.7 versus 1.8 percent). In addition, use within five days was associated with a significantly greater rate of intraoperative transfusions (23 verus 20 percent), but a nonsignificant difference in the number of reoperations for bleeding (3.4 versus 2.4 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Postoperative aspirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    therapy in the early postoperative period appears to have significant mortality and morbidity benefits in patients who undergo CABG. This was suggested in an initial randomized trial in which 407 patients were assigned to either placebo or to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/25/41366?source=see_link\">",
"     dipyridamole",
"    </a>",
"    (begun two days before surgery) plus aspirin (begun seven hours after surgery) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/9\">",
"     9",
"    </a>",
"    ]. Antiplatelet therapy significantly reduced the rate of graft occlusion at 30 days (6 versus 22 percent).",
"   </p>",
"   <p>",
"    A benefit from postoperative",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    was also suggested in a prospective observational study of over 5000 patients who survived the first 48 hours after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/7\">",
"     7",
"    </a>",
"    ]. Among patients treated with antiplatelet agents, such therapy was discontinued before surgery in 50 percent; after surgery, aspirin (at a dose of up to 650 mg) was given at the discretion of the physician.",
"   </p>",
"   <p>",
"    The following benefits were noted in the 60 percent of patients who received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    within 48 hours of revascularization; deaths or complications occurring before 48 hours were excluded from the analysis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      was associated with significant reductions in subsequent in-hospital mortality (1.3 versus 4.0 percent), MI (2.8 versus 5.4 percent), stroke (1.3 versus 2.6 percent), acute renal failure (0.9 versus 3.4 percent), and bowel infarction (0.3 versus 0.8 percent).",
"     </li>",
"     <li>",
"      The mortality benefit with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      was seen in all subgroups, but was much less (27 percent reduction) and not significant when aspirin was begun after 48 hours.",
"     </li>",
"     <li>",
"      Small differences between the study groups could not account for the difference in outcomes. Furthermore, on multivariate analysis, no other factor or medication was independently associated with reduced rates of the above outcomes.",
"     </li>",
"     <li>",
"      There was no increase in the rate of bleeding, gastritis, infection, or impaired wound healing.",
"     </li>",
"     <li>",
"      The practices of giving platelet transfusions after reperfusion and of administering antifibrinolytic drugs (such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30311?source=see_link\">",
"       aminocaproic acid",
"      </a>",
"      ) to minimize postoperative bleeding were associated with",
"      <strong>",
"       increases",
"      </strong>",
"      in mortality and ischemic complications in both",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      users and nonusers; however, the outcomes were again better with aspirin therapy. The adverse effects of antifibrinolytic therapy in this report are in contrast to a number of other studies that have demonstrated no adverse effect on or a reduction in perioperative mortality. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35226?source=see_link&amp;anchor=H8#H8\">",
"       \"Early noncardiac complications of coronary artery bypass graft surgery\", section on 'Bleeding'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The benefits of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy and the adverse effect of platelet transfusion suggest that platelet activation plays an important role in the ischemic response to reperfusion injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Aspirin summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, concerns about bleeding risk led to the recommendation that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    be discontinued three to five days before surgery in patients undergoing elective CABG. However, this general approach is no longer recommended. The 2011",
"    <span class=\"nowrap\">",
"     ACCF/AHA",
"    </span>",
"    guideline for CABG recommended that aspirin be started or continued preoperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among stable patients not previously on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , benefit may be seen with aspirin started one hour after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/10,13\">",
"     10,13",
"    </a>",
"    ]. However, with increasing experience, some surgeons recommend continuation of aspirin throughout the preoperative period. As noted above, preoperative aspirin may be associated with a significant reduction in in-hospital mortality without a significant increase in bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/4-6,14\">",
"     4-6,14",
"    </a>",
"    ]. Furthermore, cessation of aspirin before CABG may be associated with an increase in in-hospital mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Preoperative aspirin'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We suggest that, in patients already being treated,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    be continued perioperatively with the possible exception of those at high risk for bleeding. Some of the deleterious effects of aspirin and other antiplatelet drugs on postoperative bleeding and transfusion requirements can be attenuated by antifibrinolytic therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35226?source=see_link&amp;anchor=H8#H8\">",
"     \"Early noncardiac complications of coronary artery bypass graft surgery\", section on 'Bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients at increased risk of a cardiovascular thrombotic event, we typically continue",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    until the day of surgery. Aspirin is restarted at six hours or after extubation, whichever comes first. Maintenance aspirin (75 to 325",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    is continued indefinitely for secondary prevention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/15\">",
"     15",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"     Clopidogrel",
"    </a>",
"    (75",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    is an alternative in patients with contraindications to aspirin. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37066?source=see_link\">",
"     \"Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PLATELET P2Y12 RECEPTOR BLOCKER THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of concerns about increased bleeding and the association of perioperative transfusion with adverse short and long term effects, the usual recommendation has been to discontinue platelet P2Y12 receptor blocker therapy five to seven days before surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. This is not a problem in patients undergoing elective CABG, but is a potential problem in patients with a non-ST elevation acute coronary syndrome with an intended invasive strategy. In such patients, it is not known until angiography is performed whether percutaneous coronary intervention (PCI) with stenting or CABG is the preferred procedure. Early P2Y12 therapy is desirable with stenting to prevent stent thrombosis but may increase the risk of bleeding in the minority of patients who will require CABG.",
"   </p>",
"   <p>",
"    The therapeutic options in this setting are discussed in detail elsewhere. For surgeons who prefer to operate without P2Y12 receptor blocker on board, such therapy can be started after angiography if PCI is indicated., (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=see_link&amp;anchor=H1354842#H1354842\">",
"     \"Antiplatelet agents in acute non-ST elevation acute coronary syndromes\", section on 'Early CABG'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The issue of whether",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    should be restarted after CABG in patients with acute coronary syndromes (and continued for up to 9 to 12 months as is done in patients not treated with CABG) has not been adequately addressed. A suggestion of benefit from long-term P2Y12 receptor blocker therapy in non-ST elevation acute coronary syndrome patients (ACS) patients who have been revascularized with coronary artery bypass grafting (CABG) comes from a subset analysis of the CURE trial and a large registry:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the CURE trial (discussed above), there was a non-significant decrease in the risk of the primary combined end point of cardiovascular death, MI, or stroke in the subgroup of patients who underwent CABG (14.5 versus 16.2 percent, respectively; relative risk 0.89, 95% CI 0.71-1.11) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/18\">",
"       18",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=see_link&amp;anchor=H16#H16\">",
"       \"Antiplatelet agents in acute non-ST elevation acute coronary syndromes\", section on 'Clopidogrel'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A Danish registry study evaluated long term outcomes in 945 patients who underwent CABG within 180 days of myocardial infarction and who claimed a prescription for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      within 30 days after discharge [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/19\">",
"       19",
"      </a>",
"      ]. Compared to a propensity matched group that did not receive clopidogrel, there was a nearly significant reduction in the risk of death or recurrent myocardial infarction (4.0 versus 6.0 percent, respectively; hazard ratio 0.67, 95% CI 0.44-1.00) in the CABG group at a mean follow up of 466 days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Our experts are divided on this issue, with some prescribing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    after CABG in patients with ACS and others not. The 2011 American College of Cardiology",
"    <span class=\"nowrap\">",
"     Foundation/American",
"    </span>",
"    Heart Association guideline for CABG does not make a recommendation for or against the addition of clopidogrel in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"     Clopidogrel",
"    </a>",
"    is recommended in patients allergic to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    . (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Postoperative aspirin'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ANTIARRHYTHMIC DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta blockers (including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/13/21721?source=see_link\">",
"     sotalol",
"    </a>",
"    ) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    appear to reduce the likelihood of the development of atrial arrhythmias after cardiac surgery. The use of beta blockers, sotalol, and amiodarone to prevent postoperative AF is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/59/28602?source=see_link&amp;anchor=H13#H13\">",
"     \"Atrial fibrillation and flutter after cardiac surgery\", section on 'Prevention of AF and complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the prevention of postoperative atrial arrhythmias, retrospective observational data suggest that beta blocker therapy may also reduce short-term mortality. This potential benefit was illustrated in a review of almost 630,000 patients in the Society of Thoracic Surgeons National Adult Cardiac Surgery Database who underwent isolated CABG between 1996 and 1999 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/20\">",
"     20",
"    </a>",
"    ]. After adjusting for patient risk and the type of center at which CABG was performed, those who received preoperative beta blockers had a significantly lower 30-day mortality compared to those not receiving these drugs (2.8 versus 3.4 percent; adjusted odds ratio [OR] 0.94, 95% CI 0.91 to 0.97). Benefit was seen in all subsets of patients, except for those with an LVEF below 30 percent, in whom there was a nonsignificant increase in mortality with beta blockers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     GLYCEMIC CONTROL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most clinicians accept that prevention of uncontrolled hyperglycemia in critically ill patients, including those who have undergone CABG, is a desirable intervention. However, the optimal blood glucose range is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/21\">",
"     21",
"    </a>",
"    ]. Numerous clinical trials have compared different ranges of blood glucose in various populations of critically ill patients, including patients who have undergone CABG. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=see_link&amp;anchor=H6#H6\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\", section on 'Surgical patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     STATINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a long-term mortality benefit from statin therapy in patients with coronary heart disease, including those who undergo CABG. In addition, statin therapy is associated with lower crude in-hospital mortality when given to patients undergoing major noncardiac (usually vascular) surgery within the first two hospital days compared to either later or no statin therapy. The supportive data are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/2/37930?source=see_link&amp;anchor=H31#H31\">",
"     \"Long-term outcome after coronary artery bypass graft surgery\", section on 'Lipid lowering'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/45/29402?source=see_link&amp;anchor=H33#H33\">",
"     \"Management of cardiac risk for noncardiac surgery\", section on 'Statins'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The potential benefit of preoperative statins on early post-CABG outcomes has not been well studied in randomized trials. One small trial, which compared",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/11/10424?source=see_link\">",
"     rosuvastatin",
"    </a>",
"    to placebo, found a reduction in myocardial damage as assessed by measurement of biomarkers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A 2008 meta-analysis of 19 studies with more than 31,000 patients addressed this issue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/23\">",
"     23",
"    </a>",
"    ]. Compared to no preoperative statin therapy, preoperative statin use was associated with the following benefits:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A significant 1.5 percent absolute reduction in all-cause mortality in over 28,000 patients (2.2 versus 3.7 percent, odds ratio 0.57, 95% CI 0.49-0.67).",
"     </li>",
"     <li>",
"      A significant reduction in the risk of development of atrial fibrillation (24.9 versus 29.3 percent) and stroke (2.1 versus 2.9 percent) in over 7000 and 16,000 patients respectively.",
"     </li>",
"     <li>",
"      No significant difference in the rates of myocardial infarction or acute renal failure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon such observations, patients with known coronary heart disease should be on long-term statin therapy prior to elective CABG with the dose titrated to recommended goals for secondary prevention. When time does not permit dose titration, we believe it is reasonable to initiate statin therapy soon before CABG, with an initial drug and dose that takes into account the patient's treatment goal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=see_link\">",
"     \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H112271285\">",
"    <span class=\"h1\">",
"     ANGIOTENSIN CONVERTING ENZYME INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal use of angiotensin converting enzyme (ACE) inhibitors around the time of CABG is not well established. Many patients undergoing CABG are taking long-term ACE inhibitors. We believe it is reasonable to continue ACE inhibitor after CABG in such patients who are hemodynamically stable.",
"   </p>",
"   <p>",
"    It has been postulated that ACE inhibitors might improve outcomes at the time of CABG as the renin-angiotensin-aldosterone system is hyperactive during and after cardiopulmonary bypass (CPB). This hyperactivity is thought to be a mediator of microvascular injury and a trigger of endothelial dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/43/14008?source=see_link&amp;anchor=H2#H2\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in heart failure: Mechanisms of action\", section on 'Angiotensin converting enzyme inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some studies of perioperative ACE inhibitor use have shown improved outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/24,25\">",
"     24,25",
"    </a>",
"    ] while others have demonstrated worse outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/26\">",
"     26",
"    </a>",
"    ]. Reports of intraoperative",
"    <span class=\"nowrap\">",
"     hypotension/vasoplegia",
"    </span>",
"    in patients taking ACE inhibitors have led to the widespread practice of not performing elective surgery unless the medication had been held for a number of days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential role of ACE inhibitor was addressed in a prospective, observational study of 4224 patients undergoing CABG with CPB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/29\">",
"     29",
"    </a>",
"    ]. In this study, four groups of patients were identified: ACE inhibitor before and after surgery (continuation); ACE inhibitor before but not after surgery (withdrawal); no ACE inhibitor at any time (never); and no ACE inhibitor before but ACE inhibitor after CABG (addition). The percent of patients in each group were 21.7, 21.8, 48.4, and 8.1, respectively. ACE inhibitor was generally held the day before CABG; the decision to start (and the timing of) therapy was at the discretion of the managing physician.",
"   </p>",
"   <p>",
"    The following findings were noted for the primary composite outcome of in-hospital death, cardiovascular event (heart failure or myocardial infarction), cerebrovascular event, or renal event:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary outcomes occurred in 12.8, 28.1, 14.1, and 11.6 percent of cases, respectively.",
"     </li>",
"     <li>",
"      The adjusted odds ratio (OR) comparing the following pairs of groups were:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      continuation versus never: 0.69, 95% CI 0.52-0.91;",
"     </li>",
"     <li>",
"      continuation versus withdrawal: 0.50, 95% CI 0.38-0.66;",
"     </li>",
"     <li>",
"      addition versus never: 0.56, 95% CI 0.38-0.84",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No differences in in-hospital mortality and cerebral events were seen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We and others are concerned about the limitations of this observational study, including multiple potential sources of bias, and the inability to extrapolate to other patient groups, such as those undergoing valve surgery or off-pump CABG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/30\">",
"     30",
"    </a>",
"    ]. Until further evidence is available to support the findings of this study, we believe it is reasonable to continue ACE inhibitor after CABG in hemodynamically stable patients taking this therapy before surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     GLUCOCORTICOID THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiopulmonary bypass initiates a systemic inflammatory response and glucocorticoid therapy is effective in lessening this response; thus, a potential role for routine preoperative glucocorticoid has been postulated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/31\">",
"     31",
"    </a>",
"    ]. Based on the totality of evidence presented below, including no improvement in mortality and a worsening in hyperglycemia, we do not recommend the routine preoperative use of glucocorticoids, except for patients who are receiving them chronically.",
"   </p>",
"   <p>",
"    In three meta-analyses of up to 54 trials (including up to 3615), glucocorticoid use (at varying doses and varying preparations) was associated with the following outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A significant reduction in the onset of atrial fibrillation and an associated shortening of the length of stay in both the intensive care unit and hospital. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/59/28602?source=see_link&amp;anchor=H97330379#H97330379\">",
"       \"Atrial fibrillation and flutter after cardiac surgery\", section on 'Ineffective or possibly effective therapies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A significant reduction in the incidence of postoperative bleeding. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35226?source=see_link&amp;anchor=H13#H13\">",
"       \"Early noncardiac complications of coronary artery bypass graft surgery\", section on 'Glucocorticoids'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      No significant impact on mortality.",
"     </li>",
"     <li>",
"      No increase in wound, gastrointestinal or infectious complications was seen, although these events occurred too infrequently to allow for firm conclusions.",
"     </li>",
"     <li>",
"      Hyperglycemia requiring insulin infusion is seen in approximately 25 percent of patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The DECS study was published subsequent to the meta-analyses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/34\">",
"     34",
"    </a>",
"    ]. In DECS, 4494 patients undergoing cardiac surgery were randomly assigned to either a single intraoperative dose of 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    or placebo. At 30 days, there was no significant difference in the composite primary end point of death, myocardial infarction, stroke, renal failure, or respiratory failure (7.0 versus 8.5 percent, respectively; relative risk [RR] 0.83, 95% CI 0.67-1.01). The only component of the composite end point that was statistically lower was the rate of respiratory failure (3.0 versus 4.3 percent; RR 0.69, 95% CI 0.51-0.94).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ANTIFIBRINOLYTIC AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In selected patients, antifibrinolytic agents such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30311?source=see_link\">",
"     aminocaproic acid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/58/14248?source=see_link\">",
"     tranexamic acid",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/52/6982?source=see_link\">",
"     aprotinin",
"    </a>",
"    , can reduce the amount of blood loss and the need for blood transfusions. The possible use of these drugs is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35226?source=see_link&amp;anchor=H8#H8\">",
"     \"Early noncardiac complications of coronary artery bypass graft surgery\", section on 'Bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PYRIDOXAL 5'-PHOSPHATE MONOHYDRATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pyridoxal 5'-phosphate monohydrate (MC-1), a naturally occurring metabolite of pyridoxine (vitamin B6), prevents cellular calcium overload after ischemia driven reperfusion injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Despite modest evidence for clinical benefit in a phase 2 trial, MC-1 did not reduce the composite end point of cardiovascular death or nonfatal MI compared to placebo in the MEND-CABG II trial of over 3000 moderate to high risk CABG patients undergoing cardiopulmonary bypass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83132656\">",
"    <span class=\"h1\">",
"     ACADESINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative ischemia with reperfusion injury is an important cause of myocardial infarction, left ventricular systolic dysfunction, and death in patients undergoing CABG or percutaneous coronary intervention. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/15/6394?source=see_link\">",
"     \"Ischemic reperfusion injury of the heart\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ischemic preconditioning is a potential therapy to reduce the severity of reperfusion injury and adenosine has been shown to be a facilitator of ischemic preconditioning. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/28/9673?source=see_link&amp;anchor=H2#H2\">",
"     \"Definition and pathogenesis of ischemic preconditioning\", section on 'Ischemic preconditioning'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/28/9673?source=see_link&amp;anchor=H6#H6\">",
"     \"Definition and pathogenesis of ischemic preconditioning\", section on 'Adenosine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While the administration of adenosine during CABG has not been shown to be beneficial, acadesine, an adenosine-regulating agent that increases intracellular levels of adenosine, reduced the rate of perioperative MI and death in a 1997 meta-analysis of five relatively small randomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/38\">",
"     38",
"    </a>",
"    ]. However, since the late 1990s, perioperative mortality and non-fatal cardiovascular events have fallen by up to 40 percent, probably attributable to improvements in perioperative management and in myocardial protection techniques. Thus, we feel that the findings in this meta-analysis may not apply to patients cared for more recently.",
"   </p>",
"   <p>",
"    The RED-CABG trial, which randomly assigned intermediate- to high-risk patients undergoing nonemergency CABG to either perioperative acadesine or placebo, was designed to better evaluate the efficacy of acadesine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40360/abstract/39\">",
"     39",
"    </a>",
"    ]. The trial was stopped after enrollment of 3080 of the originally projected 7500 patients, as the results of a prespecified futility analysis found no difference in the rate (approximately 5 percent in both groups) of the primary composite outcome of all-cause mortality, nonfatal stroke, or need for mechanical support for severe left ventricular dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/62/31717?source=see_link\">",
"       \"Patient information: Coronary artery bypass graft surgery (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/16/23813?source=see_link\">",
"       \"Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2604450\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of the following drugs or interventions in the perioperative period around coronary artery bypass graft surgery is associated improved outcomes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      to improve morbidity and mortality (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Aspirin'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Beta blockers to prevent perioperative atrial fibrillation (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Antiarrhythmic drugs'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Recommendations for the management of blood glucose in critically ill patients are found elsewhere. (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=see_link&amp;anchor=H16#H16\">",
"       \"Glycemic control and intensive insulin therapy in critical illness\", section on 'Summary and recommendations'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Statin therapy (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Statins'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Prophylactic antimicrobials to prevent surgical site infection (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link&amp;anchor=H13#H13\">",
"       \"Overview of control measures to prevent surgical site infection\", section on 'Cardiac surgery'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/1\">",
"      Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ 1994; 308:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/2\">",
"      Goldman S, Copeland J, Moritz T, et al. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group. Circulation 1991; 84:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/3\">",
"      Sethi GK, Copeland JG, Goldman S, et al. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. J Am Coll Cardiol 1990; 15:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/4\">",
"      Bybee KA, Powell BD, Valeti U, et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005; 112:I286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/5\">",
"      Dacey LJ, Munoz JJ, Johnson ER, et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 2000; 70:1986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/6\">",
"      Sun JC, Crowther MA, Warkentin TE, et al. Should aspirin be discontinued before coronary artery bypass surgery? Circulation 2005; 112:e85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/7\">",
"      Mangano DT, Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/8\">",
"      Jacob M, Smedira N, Blackstone E, et al. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation 2011; 123:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/9\">",
"      Fuster V, Chesebro JH. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation 1986; 73:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/10\">",
"      Topol EJ. Aspirin with bypass surgery--from taboo to new standard of care. N Engl J Med 2002; 347:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/11\">",
"      Henn V, Slupsky JR, Gr&auml;fe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/12\">",
"      Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:2610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/13\">",
"      Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation 1991; 83:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/14\">",
"      Cannon CP, Mehta SR, Aranki SF. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery. Ann Thorac Surg 2005; 80:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/15\">",
"      Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/16\">",
"      Ferraris VA, Ferraris SP, Moliterno DJ, et al. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg 2005; 79:1454.",
"     </a>",
"    </li>",
"    <li>",
"     Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. www.acc.org/qualityandscience/clinical/statements.htm (Accessed on August 24, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/18\">",
"      Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004; 110:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/19\">",
"      S&oslash;rensen R, Abildstr&oslash;m SZ, Hansen PR, et al. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction. J Am Coll Cardiol 2011; 57:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/20\">",
"      Ferguson TB Jr, Coombs LP, Peterson ED, Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002; 287:2221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/21\">",
"      Qaseem A, Humphrey LL, Chou R, et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011; 154:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/22\">",
"      Mannacio VA, Iorio D, De Amicis V, et al. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 2008; 136:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/23\">",
"      Liakopoulos OJ, Choi YH, Haldenwang PL, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 2008; 29:1548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/24\">",
"      Oosterga M, Voors AA, Pinto YM, et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol 2001; 87:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/25\">",
"      Kj&oslash;ller-Hansen L, Steffensen R, Grande P. The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES). J Am Coll Cardiol 2000; 35:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/26\">",
"      Miceli A, Capoun R, Fino C, et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2009; 54:1778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/27\">",
"      Tuman KJ, McCarthy RJ, O'Connor CJ, et al. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995; 80:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/28\">",
"      Oh YJ, Lee JH, Nam SB, et al. Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass. Br J Anaesth 2006; 97:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/29\">",
"      Drenger B, Fontes ML, Miao Y, et al. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality. Circulation 2012; 126:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/30\">",
"      Barodka V, Nyhan D, Berkowitz D. About fACE: perioperative use of angiotensin-converting enzyme inhibitors. Circulation 2012; 126:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/31\">",
"      Whitlock RP, Chan S, Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J 2008; 29:2592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/32\">",
"      Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation 2009; 119:1853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/33\">",
"      Dieleman JM, van Paassen J, van Dijk D, et al. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev 2011; :CD005566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/34\">",
"      Dieleman JM, Nierich AP, Rosseel PM, et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 2012; 308:1761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/35\">",
"      Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/36\">",
"      Tardif JC, Carrier M, Kandzari DE, et al. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. J Thorac Cardiovasc Surg 2007; 133:1604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/37\">",
"      MEND-CABG II Investigators, Alexander JH, Emery RW Jr, et al. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. JAMA 2008; 299:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/38\">",
"      Mangano DT. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. JAMA 1997; 277:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40360/abstract/39\">",
"      Newman MF, Ferguson TB, White JA, et al. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. JAMA 2012; 308:157.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1556 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-C815FD8784-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40360=[""].join("\n");
var outline_f39_26_40360=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2604450\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ASPIRIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Preoperative aspirin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Postoperative aspirin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Aspirin summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PLATELET P2Y12 RECEPTOR BLOCKER THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ANTIARRHYTHMIC DRUGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      GLYCEMIC CONTROL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      STATINS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H112271285\">",
"      ANGIOTENSIN CONVERTING ENZYME INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      GLUCOCORTICOID THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ANTIFIBRINOLYTIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PYRIDOXAL 5'-PHOSPHATE MONOHYDRATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H83132656\">",
"      ACADESINE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2604450\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/43/14008?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in heart failure: Mechanisms of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=related_link\">",
"      Antiplatelet agents in acute non-ST elevation acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/59/28602?source=related_link\">",
"      Atrial fibrillation and flutter after cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37066?source=related_link\">",
"      Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/28/9673?source=related_link\">",
"      Definition and pathogenesis of ischemic preconditioning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35226?source=related_link\">",
"      Early noncardiac complications of coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=related_link\">",
"      Glycemic control and intensive insulin therapy in critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=related_link\">",
"      Intensity of lipid lowering therapy in secondary prevention of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/15/6394?source=related_link\">",
"      Ischemic reperfusion injury of the heart",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/2/37930?source=related_link\">",
"      Long-term outcome after coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/45/29402?source=related_link\">",
"      Management of cardiac risk for noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/51/9018?source=related_link\">",
"      Medical therapy versus revascularization in the management of stable angina pectoris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/62/31717?source=related_link\">",
"      Patient information: Coronary artery bypass graft surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/16/23813?source=related_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_26_40361="H and E stain of chronic sclerosing sialadenitis";
var content_f39_26_40361=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F67582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F67582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    H and E stain of chronic sclerosing sialadenitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic sclerosing sialadenitis (Kuttner tumor). This IgG4-related disease shows large germinal centers (arrow), dense lymphoplasmacytic inflammation and fibrosis. The cellular fibro-inflammatory stroma is typical of this disease (arrowhead) (H&amp;E stain).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Geyer J, Deshpande V. IgG4-associated sialadenitis. Curr Opinion Rheum 2011; 23:95. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40361=[""].join("\n");
var outline_f39_26_40361=null;
var title_f39_26_40362="Long-term management of adult liver transplant recipients";
var content_f39_26_40362=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Long-term management of adult liver transplant recipients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/26/40362/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40362/contributors\">",
"     Paul J Gaglio, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40362/contributors\">",
"     Scott J Cotler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/26/40362/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40362/contributors\">",
"     Robert S Brown, Jr, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/26/40362/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/26/40362/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/26/40362/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver transplantation is the treatment of choice for appropriately selected patients with end-stage liver disease. With improved long-term survival, more patients are being cared for outside of a transplant center, requiring more widespread familiarity with the complications seen in this patient population. Several medical problems are routinely encountered by clinicians caring for patients after liver transplantation. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute or chronic rejection",
"     </li>",
"     <li>",
"      Complications of immunosuppression including hypertension, renal insufficiency, infection, malignancy, a variety of dermatologic conditions, and metabolic diseases such as diabetes mellitus, obesity, hyperlipidemia, and bone disease",
"     </li>",
"     <li>",
"      Biliary complications",
"     </li>",
"     <li>",
"      Recurrence of the primary liver disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the general management of patients following liver transplantation and the nonimmunologic complications of liver transplantation. Acute and chronic rejection, infectious complications of liver transplantation, recurrent hepatitis, and recurrent hepatocellular carcinoma are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/28/37319?source=see_link\">",
"     \"Diagnosis of acute cellular rejection in liver transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16842?source=see_link\">",
"     \"Infectious complications in liver transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16474?source=see_link\">",
"     \"Liver transplantation for hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/2/15402?source=see_link\">",
"     \"Liver transplantation for chronic hepatitis B virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=see_link\">",
"     \"Liver transplantation for hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1052710311\">",
"    <span class=\"h1\">",
"     ROLE OF THE PRIMARY CARE CLINICIAN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediately following liver transplantation, patients are managed by transplant surgeons",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    transplant hepatologists. However, after several months, the general medical care of a liver transplant recipient is often transferred back to the patient's primary care clinician [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/1\">",
"     1",
"    </a>",
"    ]. While practices vary in different transplant centers, the transplant center typically continues to manage the administration of immunosuppressive agents, to treat recurrent liver disease, and to manage biliary complications. In addition, the transplant center may also manage some of the complications of immunosuppression, such as renal disease. The patient's other medical issues, including other complications of immunosuppression, are often managed by the primary care clinician.",
"   </p>",
"   <p>",
"    In general, transplant centers and primary care clinicians experienced with caring for patients who have undergone liver transplantation have similar expectations regarding who should manage various aspects of the patient's care. A survey of the liver transplant coordinators from 45 programs examined opinions regarding which health care provider(s) should primarily be responsible for the patient's general medical care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/1\">",
"     1",
"    </a>",
"    ]. Most reported that the primary clinician who should be responsible for the overall care of the patient six months after transplantation is the patient's family",
"    <span class=\"nowrap\">",
"     practitioner/internist",
"    </span>",
"    (40 percent). Others favored that the care be provided by a transplant hepatologist (35 percent), a primary care clinician in conjunction with a hepatologist (14 percent), or a transplant surgeon (11 percent). None reported that the referring gastroenterologist should be the primary care giver.",
"   </p>",
"   <p>",
"    In addition, the survey looked at which elements of the patient's care transplant centers wanted the primary care clinician to manage:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preventive medicine &ndash; 100 percent",
"     </li>",
"     <li>",
"      Annual examinations &ndash; 65 percent",
"     </li>",
"     <li>",
"      Vaccinations &ndash; 65 percent",
"     </li>",
"     <li>",
"      Diabetes &ndash; 60 percent",
"     </li>",
"     <li>",
"      Bone disease &ndash; 40 percent",
"     </li>",
"     <li>",
"      Hypertension &ndash; 37 percent",
"     </li>",
"     <li>",
"      Pregnancy &ndash; 15 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All of the transplant centers wanted to manage the immunosuppressive regimen, graft rejection, infections, recurrent liver disease, and renal dysfunction.",
"   </p>",
"   <p>",
"    Finally, the survey asked primary care clinicians who had experience caring for liver transplant recipients whether they felt comfortable managing the patient's overall health care following transplantation. Seventy-three percent of respondents reported they were comfortable managing the patient's health care. In particular, they were comfortable managing liver transplant recipient's hypertensive medications (100 percent), general preventive care (91 percent), annual physical examinations (91 percent), diabetes mellitus (82 percent), hyperglycemia (82 percent), vaccinations (82 percent), and bone disease (73 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1052710303\">",
"    <span class=\"h1\">",
"     PREVENTIVE MEDICINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;General health maintenance for liver transplant recipients is similar to that for the general population. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37962?source=see_link\">",
"     \"Overview of preventive medicine in adults\"",
"    </a>",
"    .) However, certain disorders require more intensive screening because they are more common following liver transplantation (eg, hypertension, diabetes, dyslipidemia, renal disease, and malignancy). In addition, because there are numerous drugs that interact with immunosuppressive agents, at each visit patients should be asked about any new medications or supplements they are taking (including over the counter medications) and be reminded not to start any new medications or supplements without first talking to their clinicians (",
"    <a class=\"graphic graphic_table graphicRef81998 \" href=\"mobipreview.htm?14/44/15042\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H154135359\">",
"     'Immunosuppression'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18145336\">",
"    <span class=\"h2\">",
"     Screening for nonmalignant disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our approach to screening for nonmalignant diseases in liver transplant recipients includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      General assessment: Annual history and physical examination, annual dental evaluations in addition to routine (twice yearly) cleanings.",
"     </li>",
"     <li>",
"      Hypertension: For the first six months following transplantation, self-monitoring every week and blood pressure monitoring by a health care provider every month. In patients without hypertension after six months, blood pressure monitoring by a health care provider every six months. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/36/32330?source=see_link&amp;anchor=H13#H13\">",
"       \"Overview of hypertension in adults\", section on 'Measurement'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diabetes mellitus: Screening every six months (typically with either a fasting plasma glucose or a hemoglobin A1C) and an annual eye examination to look for cataracts or diabetic changes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/16/2312?source=see_link&amp;anchor=H13#H13\">",
"       \"Screening for diabetes mellitus\", section on 'A suggested approach'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dyslipidemia: Annual fasting lipid profile. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31222?source=see_link\">",
"       \"Measurement of serum lipids and lipoproteins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cardiovascular disease: We perform stress testing every three to five years in patients with risk factors for coronary artery disease and more frequently in patients with pre-existing coronary artery disease. Exercise stress testing is preferred for those who are able to do the test. For those unable to do exercise stress testing, adenosine and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress tests are alternatives. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26521?source=see_link\">",
"       \"Stress testing for the diagnosis of coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Renal disease: During the first year, urinalysis, microalbumin, and determination of the",
"      <span class=\"nowrap\">",
"       creatinine/glomerular",
"      </span>",
"      filtration rate every two to three months. After the first year, we obtain the tests every six months. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/60/35785?source=see_link&amp;anchor=H12#H12\">",
"       \"Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease\", section on 'Assessment of kidney function'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metabolic bone disease: Bone mineral density measurement prior to transplantation and every other year after transplantation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42583?source=see_link\">",
"       \"Overview of dual-energy x-ray absorptiometry\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18145343\">",
"    <span class=\"h2\">",
"     Screening for malignancies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both skin cancer and non-skin malignancies are more common following liver transplantation than they are in the general public. As a result, we perform intensive screening in this population. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'De novo malignancy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18145432\">",
"    <span class=\"h2\">",
"     Immunizations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunizations recommended for patients receiving solid organ transplantations include vaccinations for influenza, pneumonia, and hepatitis A and B (",
"    <a class=\"graphic graphic_table graphicRef61599 \" href=\"mobipreview.htm?13/52/14157\">",
"     table 2",
"    </a>",
"    ). Because immunosuppression can affect the patient's ability to mount an immune response to vaccinations, it is recommended that many of the vaccinations (eg, hepatitis A and B vaccines) be administered prior to transplantation when possible. In addition, live virus vaccinations should be avoided. The role of immunizations in patients undergoing solid organ transplantation is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/48/23306?source=see_link\">",
"     \"Immunizations in solid organ transplant candidates and recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H75299348\">",
"    <span class=\"h2\">",
"     Recommendations regarding alcohol consumption",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients should be advised to avoid excess alcohol consumption following liver transplantation. Patients who consume excessive alcohol following liver transplantation have lower survival rates than those who do not, regardless of the indication for liver transplantation. In a study of 441 patients who underwent liver transplantation for various indications, the five-year survival rates for those with and without sustained excessive alcohol consumption (&gt;20",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    for women and &gt;30",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    for men (",
"    <a class=\"graphic graphic_figure graphicRef56818 \" href=\"mobipreview.htm?20/18/20778\">",
"     figure 1",
"    </a>",
"    )) were 49 and 75 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is recommended that patients with alcoholic liver disease abstain from alcohol completely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/3\">",
"     3",
"    </a>",
"    ]. Studies have not addressed whether light to moderate alcohol consumption following liver transplantation for non-alcohol-related indications is safe. As a result, we take a conservative approach and suggest that patients abstain from alcohol following liver transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154135359\">",
"    <span class=\"h1\">",
"     IMMUNOSUPPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most transplant centers use either two or three agents to prevent allograft rejection in the immediate post-transplantation period (",
"    <a class=\"graphic graphic_table graphicRef67917 \" href=\"mobipreview.htm?38/60/39884\">",
"     table 3",
"    </a>",
"    ). This typically involves a combination of a glucocorticoid, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , a calcineurin inhibitor (CNI), such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    , and a third agent, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    . Once patients achieve adequate liver function and are free from rejection for six months, ongoing immunosuppression can often be with monotherapy, typically a CNI. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/12/30922?source=see_link\">",
"     \"Overview of immunosuppression in adult liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All immunosuppressive agents have undesired effects, the spectrum of which vary and in some cases overlap (",
"    <a class=\"graphic graphic_table graphicRef67917 \" href=\"mobipreview.htm?38/60/39884\">",
"     table 3",
"    </a>",
"    ). Common side effects include hypertension, diabetes mellitus, and renal dysfunction. In addition, there are numerous medications which may interact with immunosuppressive agents, leading to changes in the serum concentrations of the immunosuppressants (",
"    <a class=\"graphic graphic_table graphicRef81998 \" href=\"mobipreview.htm?14/44/15042\">",
"     table 1",
"    </a>",
"    ). In order to decrease the risk of graft rejection or toxicity due to drug interactions, possible interactions should be reviewed prior to starting any new medications or supplements. If there are any concerns about the safety of a given medication or supplement, they should be discussed with the patient's transplant center prior to initiation.",
"   </p>",
"   <p>",
"    The approach to immunosuppression and issues related to acute and chronic rejection following liver transplantation are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/12/30922?source=see_link\">",
"     \"Overview of immunosuppression in adult liver transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/28/37319?source=see_link\">",
"     \"Diagnosis of acute cellular rejection in liver transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41718?source=see_link\">",
"     \"Treatment of acute cellular rejection in liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154134134\">",
"    <span class=\"h1\">",
"     COMPLICATIONS OF IMMUNOSUPPRESSION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154136303\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;The leading cause of mortality following liver transplantation is infection. In one autopsy series, infections accounted for 64 percent of 321 deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/4\">",
"     4",
"    </a>",
"    ]. Serious infections occur most frequently within the first three months post-transplantation, which is the time of greatest immunosuppression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. However, patients with poor graft function who require increased levels of immunosuppression to treat recurrent cellular rejection or chronic rejection continue to be at risk for opportunistic infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/6\">",
"     6",
"    </a>",
"    ]. A variety of pathogens can cause infections post-transplantation, including bacteria, fungi, and viruses (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62475 \" href=\"mobipreview.htm?21/3/21567\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef58770 \" href=\"mobipreview.htm?21/33/22035\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16842?source=see_link\">",
"     \"Infectious complications in liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Liver transplant recipients who develop a fever or other signs of infection require urgent evaluation because even common infections, such as pharyngitis or urinary tract infections, can rapidly progress to sepsis with multiorgan failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, patients with signs of sepsis should be transferred to a transplant center whenever possible. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=see_link&amp;anchor=H2#H2\">",
"     \"Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Our approach to patients with a fever following liver transplantation begins with a thorough history and physical examination (",
"    <a class=\"graphic graphic_table graphicRef75619 \" href=\"mobipreview.htm?29/47/30459\">",
"     table 4",
"    </a>",
"    ). Laboratory and radiographic evaluation consists of complete blood count, liver enzymes, urinalysis, urine culture, sputum Gram stain, blood cultures, and chest x-ray. Abnormalities on chest x-ray or persistent pulmonary symptoms are evaluated by chest computed tomography (CT)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bronchoscopy, and abdominal symptoms are evaluated by expanded abdominal imaging, such as CT or magnetic resonance imaging with magnetic resonance cholangiopancreatography (MRCP).",
"   </p>",
"   <p>",
"    Other testing is based upon the clinical setting:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with arthralgia and leukopenia, recent treatment for rejection, or those within 90 days of transplant are tested for cytomegalovirus (CMV) by a rapid antigen assay or, preferably, quantitative polymerase chain reaction. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/25/8597?source=see_link&amp;anchor=H7#H7\">",
"       \"Diagnosis of cytomegalovirus\", section on 'Molecular amplification'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/25/8597?source=see_link\">",
"       \"Diagnosis of cytomegalovirus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An abdominal ultrasound with Doppler examination is performed in patients with cholestatic laboratory abnormalities or known biliary disease to evaluate for evidence of biliary obstruction and for hepatic artery thrombosis. We proceed to an MRCP or endoscopic retrograde cholangiopancreatography when there is clinical suspicion of a biliary stricture. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/51/826?source=see_link&amp;anchor=H4#H4\">",
"       \"The role of endoscopy in biliary complications after liver transplantation\", section on 'Diagnostic approach'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24790?source=see_link&amp;anchor=H7#H7\">",
"       \"Acute cholangitis\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A CT scan of the head and a lumbar puncture for patients presenting with headache and fever without an identified source for the fever, since meningeal signs are frequently absent in immunosuppressed transplant patients with meningitis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If a source of infection is identified, appropriate treatment should be initiated immediately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16842?source=see_link&amp;anchor=H12#H12\">",
"     \"Infectious complications in liver transplantation\", section on 'Time course of infections'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/47/29433?source=see_link&amp;anchor=H26#H26\">",
"     \"Infection in the solid organ transplant recipient\", section on 'Evaluation and management'",
"    </a>",
"    .) However, not all fevers in transplant recipients are due to infection. Graft rejection or the development of malignancy should also be considered. Liver biopsy is indicated if the above studies fail to identify a source for the fever.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154134169\">",
"    <span class=\"h2\">",
"     Metabolic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The metabolic syndrome is common among patients who have undergone liver transplantation. It is defined by a combination of hypertension, insulin",
"    <span class=\"nowrap\">",
"     resistance/diabetes,",
"    </span>",
"    dyslipidemia, and obesity (",
"    <a class=\"graphic graphic_table graphicRef53446 \" href=\"mobipreview.htm?30/44/31437\">",
"     table 5",
"    </a>",
"    ). Liver transplant recipients may meet criteria for the metabolic syndrome prior to transplantation, in which case immunosuppressive medications can exacerbate the problem. In addition, many patients will develop the metabolic syndrome de novo. A study of 252 liver transplant patients found that 52 percent had metabolic syndrome following transplantation, compared with only 5 percent prior to transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immunosuppressant use is associated with all aspects of the metabolic syndrome (",
"    <a class=\"graphic graphic_table graphicRef67917 \" href=\"mobipreview.htm?38/60/39884\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypertension: Glucocorticoids, cyclosporin&gt;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"     </li>",
"     <li>",
"      Diabetes mellitus: Glucocorticoids,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      &gt;cyclosporin",
"     </li>",
"     <li>",
"      Obesity: Glucocorticoids, cyclosporin",
"     </li>",
"     <li>",
"      Dyslipidemia: Glucocorticoids, cyclosporin&gt;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to recognize and treat the components of the metabolic syndrome because it is strongly associated with increased morbidity and mortality in liver transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=see_link\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h3\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 65 to 70 percent of liver transplant recipients develop hypertension following transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. In addition, some patients lose the normal circadian blood pressure patterns and develop nocturnal hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/12\">",
"     12",
"    </a>",
"    ]. Because hypertension is common post-transplantation, we suggest that for the first six months following transplantation, the patient's blood pressure be assessed at home with self-monitoring every week and by a health care provider every month. In patients without hypertension after six months blood pressure monitoring should be performed by a health care provider every six months. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/36/32330?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of hypertension in adults\", section on 'Measurement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cause of hypertension is multifactorial but is mostly related to the use of calcineurin inhibitors (CNIs; eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    ) and glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/13\">",
"     13",
"    </a>",
"    ]. CNIs act by increasing both systemic vascular resistance and renal vascular resistance (primarily affecting the afferent arterioles) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/14\">",
"     14",
"    </a>",
"    ]. How this occurs is incompletely understood, but increased release of vasoconstrictors, particularly endothelin, has been thought to play an important role. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=see_link&amp;anchor=H19#H19\">",
"     \"Pharmacology and side effects of cyclosporine and tacrolimus\", section on 'Hypertension'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16761?source=see_link\">",
"     \"Hypertension after renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By comparison, glucocorticoids are usually not a major risk factor for chronic hypertension in transplant recipients because of rapid dose reduction. However, they may play a contributory role, and gradual withdrawal of glucocorticoid therapy results in a fall in blood pressure in most patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are conflicting data concerning the frequency of hypertension induced by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    compared with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    . Two long-term trials, the European FK506 Multicentre Liver Study Group and the US Multicenter FK506 Liver Study Group found no difference in the frequency of hypertension between the two drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. By comparison, other trials in liver transplant recipients have found a lower incidence of late-onset hypertension with tacrolimus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. A meta-analysis of randomized trials in heart transplant recipients included eight studies that compared tacrolimus and cyclosporin with regard to hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/19\">",
"     19",
"    </a>",
"    ]. Patients who received tacrolimus were at decreased risk for developing hypertension compared with patients who received cyclosporin (relative risk 0.80; 95% confidence interval 0.69-0.93). A lesser degree of weight gain and lower doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    used with tacrolimus may have been contributing factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/17\">",
"     17",
"    </a>",
"    ]. Because of inconclusive data among liver transplant recipients, switching from cyclosporin to tacrolimus solely for treating hypertension is not recommended. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=see_link\">",
"     \"Pharmacology and side effects of cyclosporine and tacrolimus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=see_link\">",
"     \"Cyclosporine and tacrolimus nephrotoxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most transplant centers approach hypertension with a stepwise approach, including limiting salt intake, assessing CNI serum levels, and modulating CNI dose if the level is inappropriately elevated. If antihypertensive medications are required, we suggest initiating therapy with a calcium channel blocker since part of the mechanism of hypertension is thought to be due to renal arteriolar vasoconstriction (",
"    <a class=\"graphic graphic_table graphicRef81578 \" href=\"mobipreview.htm?5/36/5708\">",
"     table 6",
"    </a>",
"    ). Amlodipine, felodipine, and nicardipine are preferred as first-line agents since they are long-acting, minimally interact with CNIs, and have limited side effects. First-generation calcium channel blockers (eg, nifedipine or verapamil) may inhibit cytochrome P450, increasing CNI levels, and should be avoided.",
"   </p>",
"   <p>",
"    Up to 30 percent of patients will require more than one agent to control their blood pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/20\">",
"     20",
"    </a>",
"    ]. If calcium channel blockers are not effective or are not tolerated, we suggest the addition or substitution of a cardioselective beta blocker, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    (nonselective beta blockers may decrease portal blood flow). An angiotensin-converting enzyme (ACE) inhibitor or angtioensin-2 receptor blocker (ARB) can also be used in patients with difficult-to-control hypertension and may have additional benefits in diabetic patients with microalbuminuria. However, ACE inhibitors and ARBs may have untoward effects on renal function in patients taking CNI inhibitors and may induce hyperkalemia, so they should therefore be used with caution. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/33/39449?source=see_link&amp;anchor=H13#H13\">",
"     \"Microalbuminuria in type 2 diabetes mellitus\", section on 'ACE inhibitors/ARBs'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16761?source=see_link&amp;anchor=H20#H20\">",
"     \"Hypertension after renal transplantation\", section on 'ACE inhibitors/ARBs and other agents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diuretics are not used as primary therapy for hypertension due to concerns related to the potential to exacerbate electrolyte disturbances and dyslipidemias induced by CNIs. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=see_link&amp;anchor=H19#H19\">",
"     \"Pharmacology and side effects of cyclosporine and tacrolimus\", section on 'Hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A goal blood pressure of less than",
"    <span class=\"nowrap\">",
"     130/80",
"    </span>",
"    mmHg is reasonable for liver transplant recipients since most have multiple risk factors for cardiovascular disease (eg, diabetes, obesity, dyslipidemia). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/45/21210?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of hypertension in patients with diabetes mellitus\", section on 'Goal blood pressure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/2/29737?source=see_link&amp;anchor=H15#H15\">",
"     \"Blood pressure management in patients with atherosclerotic cardiovascular disease\", section on 'Goal blood pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154134594\">",
"    <span class=\"h3\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    , and weight gain predispose to the development of diabetes following liver transplantation. The risk also appears to be increased in patients transplanted for hepatitis C virus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/21\">",
"     21",
"    </a>",
"    ]. To screen for diabetes we obtain fasting plasma glucose levels or hemoglobin A1C every six months. We also obtain annual eye examinations to look for cataracts or diabetic changes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/16/2312?source=see_link\">",
"     \"Screening for diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who are diabetic prior to transplantation typically require insulin following transplantation. In addition, 5 to 30 percent of recipients develop de novo diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/9,22-25\">",
"     9,22-25",
"    </a>",
"    ]. Studies suggest that the incidence of de novo diabetes is higher with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    than with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    . A meta-analysis that included 16 studies with 3813 liver transplant recipients found that the risk of developing de novo insulin-requiring diabetes was significantly higher among patients treated with tacrolimus compared with those treated with cyclosporin (relative risk 1.38; 95% confidence interval 1.01-1.86) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/40/26250?source=see_link\">",
"     \"New onset diabetes after transplant (NODAT) in renal transplant recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The development of diabetes does not adversely affect survival in the first year following transplantation, but it is associated with decreased survival at 10 years. This was illustrated in a series in which 26 of 497 liver transplant recipients (5 percent) who developed diabetes mellitus post-transplantation were compared with matched nondiabetic post-transplantation controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/27\">",
"     27",
"    </a>",
"    ]. The total number of days in the hospital, graft survival, renal function, and the type and number of infections were similar between the groups during the subsequent 12 months. However, increased 10-year mortality related to infection was reported in a cohort of liver transplant recipients with sustained, new onset diabetes compared with a group of patients with established diabetes pretransplant, transient post-transplantation diabetes, or without diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lack of deleterious effects of diabetes in the first year is important clinically because diet, weight loss, and tapering of immunosuppressant medications results in amelioration or resolution of de novo diabetes in many patients. In one series of 88 patients who were not diabetic prior to liver transplantation, the prevalence of diabetes fell from 27 percent at one year to 7 percent at three years, in association with a reduction in the mean daily",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    dose from 13 to 2 mg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/22\">",
"     22",
"    </a>",
"    ]. Furthermore, some patients who remain diabetic on low doses of glucocorticoids become euglycemic after prednisone withdrawal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment of diabetes post-transplantation includes standard medical and nutritional therapy, including limiting caloric intake, an appropriate diet with weight loss, and the initiation of pharmacologic agents for treatment of diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43577?source=see_link\">",
"     \"Initial management of blood glucose in type 2 diabetes mellitus\"",
"    </a>",
"    .) In the peri- and early post-operative period, insulin is generally required. We use a combination of NPH and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/45/8922?source=see_link\">",
"     regular insulin",
"    </a>",
"    to provide coverage for postprandial increases in blood glucose. In addition, modulating immunosuppression, including lowering or stopping glucocorticoids may be of benefit. As steroids are tapered, treatment with lifestyle modification, with or without oral hypoglycemic medications may be possible. Finally, switching from",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    to cyclosporin in patients with difficult to control diabetes following liver transplantation is also an option [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/55/15225?source=see_link\">",
"     \"General principles of insulin therapy in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154134654\">",
"    <span class=\"h3\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with end-stage liver disease frequently have a compromised nutritional status. Despite this, over one-third of patients are obese [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Following transplantation, improved health and treatment with glucocorticoids or cyclosporin predispose to weight gain. Approximately one-third of patients who are normal weight at the time of transplantation will become obese following transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/9,33-35\">",
"     9,33-35",
"    </a>",
"    ]. Body weight tends to increase during the first two years after transplantation and then stabilizes. As an example, in one series of 774 patients, mean body mass index increased from 24.8",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    at baseline to 27.0",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    at year one, to 28.1",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    at year two; there was very little change with subsequent observations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/20/12615?source=see_link&amp;anchor=H7#H7\">",
"     \"Screening for and clinical evaluation of obesity in adults\", section on 'Classification of BMI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    has been identified as an independent predictor of the development of obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/34\">",
"     34",
"    </a>",
"    ]. However, once obesity is established, tapering of prednisone may not lead to weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/9\">",
"     9",
"    </a>",
"    ]. In addition, patients treated with cyclosporin are more likely to have weight gain than those who receive",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    (46 versus 27 percent in one study) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Overweight liver transplant recipients may have great difficulty losing weight. Excessive weight gain often leads to reduced physical activity, which predisposes to further weight gain and a sedentary lifestyle. Thus, prevention of excessive weight gain through patient education, nutritional counseling, and an exercise program is important for reducing post-transplantation morbidity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/28/15816?source=see_link\">",
"     \"Behavioral strategies in the treatment of obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of obesity includes caloric restriction, encouraging exercise, and tapering steroids, with an initial goal of losing one to two pounds per week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/1\">",
"     1",
"    </a>",
"    ]. If those measures fail to result in adequate weight loss, additional treatment options include switching from cyclosporin to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    and possibly bariatric surgery. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/8,37\">",
"     8,37",
"    </a>",
"    ]. Several small studies have described successful bariatric surgery using an adjustable gastric band placed during liver transplantation, confirming the feasibility of surgical modalities to control obesity in liver transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/38\">",
"     38",
"    </a>",
"    ]. Other forms of bariatric surgery, such as Roux-en-Y gastric bypass, may impair access to the biliary tree, which may be required if biliary complications develop. In addition, bypass operations may impair intestinal drug absorption, which could affect immunosuppression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/31/33274?source=see_link\">",
"     \"Surgical management of severe obesity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/51/826?source=see_link\">",
"     \"The role of endoscopy in biliary complications after liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154134668\">",
"    <span class=\"h3\">",
"     Dyslipidemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyslipidemia is common after liver transplantation, and patients should have a fasting lipid profile obtained annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/39\">",
"     39",
"    </a>",
"    ]. Hypercholesterolemia develops in 16 to 43 percent of patients and hypertriglyceridemia in 40 to 47 percent; reduced serum HDL-cholesterol is also common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Hypertriglyceridemia usually develops within the first month post-transplantation and then remains stable throughout the first year. By comparison, serum cholesterol increases gradually and plateaus at six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/41\">",
"     41",
"    </a>",
"    ]. Patients with elevated pretransplantation cholesterol levels are most likely to develop hypercholesterolemia following transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31222?source=see_link\">",
"     \"Measurement of serum lipids and lipoproteins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hyperlipidemia observed in liver transplant recipients is mostly related to the side effects of glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    . Immunosuppression consisting of tacrolimus monotherapy with early glucocorticoid withdrawal, which is common at many centers, has been associated with lower rates of hypercholesterolemia and hypertriglyceridemia at six months post-transplantation compared with dual therapy with tacrolimus and glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/42\">",
"     42",
"    </a>",
"    ]. Furthermore, tacrolimus appears to have a less prominent effect on lipids than cyclosporine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/43\">",
"     43",
"    </a>",
"    ], and there is some evidence that conversion from cyclosporine to tacrolimus can improve lipid profiles in liver transplant patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/54/29546?source=see_link\">",
"     \"Lipid abnormalities after renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment begins with dietary modification and, if possible, reducing the dose of or discontinuing glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/29\">",
"     29",
"    </a>",
"    ]. Another option is substituting",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    . In one study of renal transplant recipients, 53 patients with serum cholesterol concentrations greater than 240",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (6.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    were randomized to either the continuation of maintenance cyclosporine or conversion to tacrolimus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/45\">",
"     45",
"    </a>",
"    ]. Substitution with tacrolimus resulted in significant reductions in total and LDL-cholesterol levels (by 16 and 25 percent, respectively) at six-month follow-up, but no change in renal function or glycemic control.",
"   </p>",
"   <p>",
"    Dyslipidemia improves in many patients over time if the maintenance dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    is low. Thus, medical therapy is rarely indicated early in the course when steroid doses are relatively high. Treatment is indicated in patients whose dyslipidemia does not improve with steroid withdrawal. Treatment is similar to treatment in nontransplant recipients. However, treatment is complicated by interactions of the drugs used to treat dyslipidemia with immunosuppressive agents (",
"    <a class=\"graphic graphic_table graphicRef81998 \" href=\"mobipreview.htm?14/44/15042\">",
"     table 1",
"    </a>",
"    ). These interactions can lead to alterations in immunosuppressant levels",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased toxicities, including rhabdomyolysis. Thus, agents to treat dyslipidemia must be chosen carefully based upon the patient's immunosuppressive regimen, and immunosuppressant levels should be monitored if interactions are anticipated (",
"    <a class=\"graphic graphic_table graphicRef78053 \" href=\"mobipreview.htm?43/10/44205\">",
"     table 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Most patients are treated with a statin.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/27/25016?source=see_link\">",
"     Pravastatin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/4/8264?source=see_link\">",
"     fluvastatin",
"    </a>",
"    are preferred due to decreased interactions with immunosuppressants (",
"    <a class=\"graphic graphic_table graphicRef78053 \" href=\"mobipreview.htm?43/10/44205\">",
"     table 7",
"    </a>",
"    ). The goals of treatment depend upon whether the patient has a history of cardiovascular disease other risk factors for cardiovascular disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/32/14856?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26122?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in secondary prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/47/35578?source=see_link\">",
"     \"Approach to the patient with hypertriglyceridemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/42/4773?source=see_link\">",
"     Ezetimibe",
"    </a>",
"    has also been studied alone or as an adjunct to a statin in liver and kidney transplant recipients. It has been shown to reduce LDL levels with generally stable levels of immunosuppression and a low risk of serious side effects. However, there have been reports of myalgia, rhabdomyolysis, hepatitis, acute pancreatitis, and thrombocytopenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. In addition, studies in patients outside of the transplant setting have failed to show convincing evidence of clinical benefits from ezetimibe. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/35/32314?source=see_link\">",
"     \"Statins: Actions, side effects, and administration\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=see_link&amp;anchor=H9#H9\">",
"     \"Lipid lowering with drugs other than statins and fibrates\", section on 'Ezetimibe'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We avoid treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    because it can raise triglyceride levels and it may significantly impair the absorption of medications, including calcineurin inhibitors. We also avoid nicotinic acid because it can decrease glucose tolerance and raise uric acid levels, leading to symptomatic gout in some patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=see_link&amp;anchor=H2#H2\">",
"     \"Lipid lowering with drugs other than statins and fibrates\", section on 'Bile acid sequestrants'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=see_link&amp;anchor=H5#H5\">",
"     \"Lipid lowering with drugs other than statins and fibrates\", section on 'Nicotinic acid (Niacin)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154134702\">",
"    <span class=\"h3\">",
"     Cardiovascular risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the high rates of hypertension, diabetes, obesity, and dyslipidemia following liver transplantation, it is not surprising that coronary heart disease is also common. A meta-analysis that included 4792 patients following liver transplantation with 28,783 person-years of follow-up found that the 10-year risk of cardiovascular events was 14 percent and was particularly high among those with the metabolic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/49\">",
"     49",
"    </a>",
"    ]. Factors that have been associated with cardiovascular events include older age at transplantation, male sex, post-transplantation diabetes, post-transplantation hypertension, and use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil (MMF) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Liver transplant recipients have a greater risk of cardiovascular death and ischemic events than age- and sex-matched nontransplanted patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/49\">",
"     49",
"    </a>",
"    ]. As an example, one study compared 1312 liver transplant recipients with age- and sex-matched controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/51\">",
"     51",
"    </a>",
"    ]. The relative risk of death due to cardiovascular disease in liver transplant recipients was 2.6 (95% confidence interval 1.5-4.0) compared with controls. When excluding infection, recurrent disease, graft loss due to technical complications, and de novo malignancy, coronary heart disease represents the most common cause of death following liver transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/52\">",
"     52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report that described the cause of death in 299 adult liver transplant recipients who lived for more than three years, 8 out of 38 deaths (21 percent) were due to cardiovascular complications [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Similarly, in a study of 542 patients who survived at least one year after liver transplantation, cardiovascular events accounted for 18 of 43 non-graft related deaths (42 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study from the Netherlands evaluated cardiovascular morbidity in 37 liver transplant recipients who survived more than 15 years post-transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/55\">",
"       55",
"      </a>",
"      ]. Cardiovascular events including myocardial infarction, angina, claudication, and transient ischemic attacks occurred in 19 percent of patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As in any patient with cardiovascular disease, modification of risk factors both before and after liver transplantation is essential to maximize outcomes. Thus, treatment and prevention of obesity, hyperlipidemia, diabetes, and hypertension are priorities. At present, no clear guidelines exist related to invasive modalities (coronary angiography) or noninvasive modalities (cardiac stress testing) to assess cardiac function and coronary artery patency following liver transplantation. Our approach is to perform adenosine or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress testing every three to five years in patients with risk factors for coronary artery disease and more frequently in patients with pre-existing coronary artery disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/58/2986?source=see_link\">",
"     \"Stress testing to determine prognosis and management of patients with known or suspected coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute and chronic renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute and chronic kidney injuries are common in liver transplantation. For the first year following transplantation, we screen patients every two to three months with a urinalysis (including microalbumin assessment) and determination of the glomerular filtration rate. After the first year, we obtain the tests every six months. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/60/35785?source=see_link&amp;anchor=H12#H12\">",
"     \"Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease\", section on 'Assessment of kidney function'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The best data on the incidence of chronic kidney disease come from a cohort study of almost 37,000 liver transplant recipients who were followed for a median of 36 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/56\">",
"     56",
"    </a>",
"    ]. The incidence of chronic kidney disease (defined as an estimated GFR &lt;30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m",
"    <sup>",
"     2",
"    </sup>",
"    ) was 14 percent at three years and 18 percent at five years (",
"    <a class=\"graphic graphic_figure graphicRef54972 \" href=\"mobipreview.htm?35/21/36190\">",
"     figure 3",
"    </a>",
"    ). Risk factors for chronic renal failure included calcineurin inhibitor (CNI) therapy (given in at least 89 percent), older age, lower pretransplant GFR, female sex, postoperative acute renal failure, baseline diabetes and hypertension, hepatitis C virus infection, and transplantation before 1998.",
"   </p>",
"   <p>",
"    Another study evaluated changes in kidney function in 432 patients maintained on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    who were followed for a mean of 3.7 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/57\">",
"     57",
"    </a>",
"    ]. Estimated GFR declined &ge;30 percent after transplant in 36 percent of patients. Following a decline during the first six months post-transplantation, mean GFR remained stable for the duration of follow-up.",
"   </p>",
"   <p>",
"    The cause of kidney injury is multifactorial. Important contributing factors are pre-existing chronic kidney disease, renal failure prior to liver transplantation, acute tubular necrosis around the time of transplantation, hypertension, diabetes mellitus, and CNI toxicity. CNI-related acute renal failure is due to renal vasoconstriction and improves with dose reduction. Chronic renal disease can also be induced by these drugs, warranting continued monitoring of the plasma creatinine concentration and urinalysis. There are conflicting data about whether chronic nephrotoxicity in liver transplant recipients is more common with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/15,16,56\">",
"     15,16,56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=see_link\">",
"     \"Cyclosporine and tacrolimus nephrotoxicity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/28/34250?source=see_link\">",
"     \"Renal function and nonrenal solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Attempts to prevent or reverse CNI-related chronic kidney disease have been largely unsuccessful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/58\">",
"     58",
"    </a>",
"    ]. Several renal-sparing strategies have been proposed, including reduction or complete withdrawal of the CNI and use of antibody induction therapy to delay initiation of CNI-based therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/28/34250?source=see_link\">",
"     \"Renal function and nonrenal solid organ transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/12/30922?source=see_link&amp;anchor=H25#H25\">",
"     \"Overview of immunosuppression in adult liver transplantation\", section on 'Antibody therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A reduction in the dose of the CNI does not typically improve renal function, but may minimize disease progression. Since cyclosporin and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    appear to be associated with similar degrees of nephrotoxicity, substituting one agent for the other is unlikely to improve renal function and is not recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/15,16,60\">",
"     15,16,60",
"    </a>",
"    ]. However, substitution with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil (MMF) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    is an option since these agents are associated with a lower risk of renal injury. This strategy may result in a significant decrease in serum creatinine values, particularly when used prior to irreversible renal impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. However, immunosuppression with MMF or sirolimus monotherapy may be associated with an increased risk of acute rejection, requiring vigilance to recognize and appropriately treat this complication. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/28/37319?source=see_link\">",
"     \"Diagnosis of acute cellular rejection in liver transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41718?source=see_link\">",
"     \"Treatment of acute cellular rejection in liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has been suggested that calcium channel blockers might offer long-term protection against",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    nephrotoxicity because they block CNI-induced renal vasoconstriction (",
"    <a class=\"graphic graphic_figure graphicRef65894 \" href=\"mobipreview.htm?37/42/38573\">",
"     figure 4",
"    </a>",
"    ). However, the bulk of evidence suggests that this is not the case [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/63\">",
"     63",
"    </a>",
"    ], probably because transient renal vasoconstriction does not appear to be responsible for chronic nephrotoxicity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=see_link&amp;anchor=H17#H17\">",
"     \"Cyclosporine and tacrolimus nephrotoxicity\", section on 'Calcium channel blockers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Care should be taken to avoid exposing patients to additional causes of renal injury. Nonsteroidal anti-inflammatory drugs can precipitate renal failure in patients receiving CNIs, while other drugs, such as aminoglycoside antibiotics,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    can produce renal failure by other mechanisms. Hypertension and diabetes should also be adequately controlled. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Hypertension'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H154134594\">",
"     'Diabetes mellitus'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Metabolic bone disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone loss is an important source of morbidity in liver transplant recipients (",
"    <a class=\"graphic graphic_figure graphicRef68819 \" href=\"mobipreview.htm?10/34/10797\">",
"     figure 5",
"    </a>",
"    ), and we assess bone mineral density prior to transplantation and every other year after transplantation to assess for osteopenia or osteoporosis. The majority of bone loss and fractures occur within the first six months following transplantation, and fractures often involve the spine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/64\">",
"     64",
"    </a>",
"    ]. Patients transplanted for cholestatic liver disease are particularly vulnerable to the development of bone loss before liver transplantation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/55/29561?source=see_link&amp;anchor=H7#H7\">",
"     \"Osteoporosis after solid organ or stem cell transplantation\", section on 'Bone mineral density assessment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/8/29830?source=see_link\">",
"     \"Metabolic bone disease in primary biliary cirrhosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/63/22521?source=see_link\">",
"     \"Clinical manifestations and diagnosis of primary sclerosing cholangitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Osteopenia following transplantation mostly results from the use of glucocorticoids, although animal studies suggest that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    also increase bone resorption. Other contributing factors may include immobility, hypogonadism, and certain chronic liver diseases (eg, primary biliary cirrhosis or autoimmune hepatitis treated with glucocorticoids, alcohol-related liver disease). Treatment of patients with osteoporosis is often with a bisphosphonate. Osteoporosis following solid organ transplantation is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/55/29561?source=see_link\">",
"     \"Osteoporosis after solid organ or stem cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     De novo malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of malignancy is increased in liver transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/65\">",
"     65",
"    </a>",
"    ]. Because of the increased risk, we pursue more intensive screening than is done in the general population. (See",
"    <a class=\"local\" href=\"#H69198615\">",
"     'Screening and prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H69198694\">",
"    <span class=\"h3\">",
"     Incidence of de novo malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both skin cancer and non-skin malignancies are more common in liver transplant recipients than in the general population, with skin cancers being the most common malignancies seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34170?source=see_link\">",
"     \"Development of malignancy following solid organ transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37832?source=see_link\">",
"     \"Epidemiology and risk factors for skin cancer in solid organ transplant recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a systematic review that included nine studies with a minimum of 400 patients each, the rates of de novo malignancy in patients following liver transplantation were [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/67\">",
"     67",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Skin cancer: 0.9 to 3.2 percent, mean time to diagnosis of 36 to 50 months",
"     </li>",
"     <li>",
"      Post-transplant lymphoproliferative disorder: 0.9 to 2.6 percent, mean time to diagnosis of 26 to 32 months",
"     </li>",
"     <li>",
"      Colorectal cancer: 0 to 0.6 percent, mean time to diagnosis of 16 to 51 months",
"     </li>",
"     <li>",
"      Head and neck cancer: 0.1 to 5 percent, mean time to diagnosis of 34 to 61 months",
"     </li>",
"     <li>",
"      Lung cancer: 1 to 1.2 percent, mean time to diagnosis of 42 to 50 months",
"     </li>",
"     <li>",
"      Breast cancer: 0.2 to 0.7 percent, mean time to diagnosis of 41 to 124 months",
"     </li>",
"     <li>",
"      Cervical, uterine, or ovarian cancer: 0 to 1.5 percent, mean time to diagnosis of 1 to 59 months",
"     </li>",
"     <li>",
"      Prostate cancer: 0 to 0.3 percent, mean time to diagnosis of 6 to 18 months",
"     </li>",
"     <li>",
"      Bladder or renal cancer: 0 to 0.4 percent, mean time to diagnosis of 20 to 55 months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An analysis of a US national database published after the systematic review included 798 liver transplant recipients and identified 171 adult patients who developed 271 de novo malignancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/65\">",
"     65",
"    </a>",
"    ]. Most were skin-related, whereas 29 were hematologic and 95 were solid-organ cancers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23273?source=see_link\">",
"     \"Dermatologic problems in patients who have undergone liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The probability of developing any non-skin malignancy varied according to the underlying diagnosis. It was highest in patients with primary sclerosing cholangitis (22 percent at 10 years) and alcohol-related liver disease (18 percent at 10 years), and was about 10 percent for all other diagnoses. The risk increased with advancing age and with smoking.",
"   </p>",
"   <p>",
"    Other studies have demonstrated an association of specific cancers with particular underlying liver diseases. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary sclerosing cholangitis and ulcerative colitis with colon cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/68\">",
"       68",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/25/40342?source=see_link\">",
"       \"Colorectal cancer and primary sclerosing cholangitis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Recurrent viral hepatitis with hepatocellular carcinoma (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/38/25194?source=see_link\">",
"       \"Epidemiology and etiologic associations of hepatocellular carcinoma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Alcoholic cirrhosis with oropharyngeal squamous cell carcinoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/69\">",
"       69",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38874?source=see_link&amp;anchor=H12#H12\">",
"       \"Overview of the risks and benefits of alcohol consumption\", section on 'Oral cavity, larynx, and pharynx'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H69198615\">",
"    <span class=\"h3\">",
"     Screening and prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the increased risk of cancer in liver transplant recipients, studies have looked at the role of intensive screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. One study included 779 patients who underwent liver transplantation between 1982 and 2007 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/70\">",
"     70",
"    </a>",
"    ]. The patients were managed at a center that started to employ intensive cancer screening in 2002. Prior to 2002, the screening regimen included annual chest x-rays and abdominal ultrasounds. Urological screenings and mammographies were performed based upon standard screening recommendations for the general public. In addition, chest and abdominal computed tomography (CT) scans were performed in patients with a history of malignancy prior to transplantation.",
"   </p>",
"   <p>",
"    Starting in 2002, their screening regimen changed to include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Annual chest CT scan",
"     </li>",
"     <li>",
"      Annual abdominal CT",
"     </li>",
"     <li>",
"      Annual urologic evaluation including measurement of prostate specific antigen (PSA) in men",
"     </li>",
"     <li>",
"      Annual cervical Papanicolaou (Pap) smear in women",
"     </li>",
"     <li>",
"      Annual mammogram in women",
"     </li>",
"     <li>",
"      Annual dermatologic screening",
"     </li>",
"     <li>",
"      Colonoscopy three years after liver transplantation unless indicated sooner because of a history of an adenoma or inflammatory bowel disease, followed by colonoscopy every five years",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Between 1982 and 2001, 24 malignancies were detected in 490 patients (5 percent), and all 21 non-skin cancer malignancies were diagnosed due to symptomatic disease. Between 2002 and 2007, 81 malignancies were detected in 625 patients (13 percent), and 19 of 66 non-skin cancer malignancies (29 percent) were diagnosed by screening. In addition, the cancers were diagnosed at earlier stages compared with the earlier time period. Survival among patients diagnosed with a malignancy during intensive surveillance was 3.3 years after diagnosis, which was significantly longer than patients during the earlier time period (1.2 years). In addition, overall survival following liver transplantation was longer among patients undergoing intensive surveillance (11.3 versus 3.1 years). However, it should be noted that the there is a potential for lead-time bias when comparing survival among patients who underwent intensive surveillance and those who did not. In addition, other aspects of patient care may have also changed between the two time periods, so factors other than surveillance may have contributed to the increased survival. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/46/34537?source=see_link&amp;anchor=H19#H19\">",
"     \"Evidence-based approach to prevention\", section on 'Lead-time bias'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Our approach to intensive screening is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Annual physical examination including examination of the oropharynx and a full body dermatologic examination.",
"     </li>",
"     <li>",
"      Annual urinalysis.",
"     </li>",
"     <li>",
"      Annual PSA in men.",
"     </li>",
"     <li>",
"      Annual Pap smear and mammography in women.",
"     </li>",
"     <li>",
"      Annual hepatocellular carcinoma surveillance with abdominal magnetic resonance imaging (MRI) in patients with recurrent viral hepatitis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      in patients who were transplanted for hepatocellular carcinoma or were found to have hepatocellular carcinoma in their explanted liver. However, for patients with recurrent viral hepatitis, some centers reserve hepatocarcinoma surveillance for patients who progress to bridging fibrosis or cirrhosis, which is a reasonable alternative.",
"     </li>",
"     <li>",
"      Colonoscopy three years after liver transplantation (one year if there is a history of adenoma or inflammatory bowel disease), followed by colonoscopy every three to five years, unless indicated sooner based upon the patient's history. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32746?source=see_link\">",
"       \"Approach to the patient with colonic polyps\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/61/28634?source=see_link\">",
"       \"Surveillance after colorectal cancer resection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/7/25722?source=see_link\">",
"       \"Colorectal cancer surveillance in inflammatory bowel disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/41/9881?source=see_link&amp;anchor=H11#H11\">",
"       \"Screening for colorectal cancer: Strategies in patients with possible increased risk due to family history\", section on 'Patients with a family history of FAP or HNPCC'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Since there is a risk of cancer related to radiation exposure from CT scans, we prefer abdominal MRIs to CT scans. Abdominal and pelvic ultrasounds are other alternatives to abdominal CT scans. However, these approaches have not been validated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While chest x-rays expose patients to lower radiation doses than CT scans, they have not proven effective for decreasing lung cancer mortality, whereas some studies suggest a decrease in mortality with CT scanning. Low-dose helical CT scanning using multidetector CT scanners decreases the radiation dose (2 mSv compared with 7 mSv for a standard-dose diagnostic chest CT scan). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/58/28586?source=see_link\">",
"     \"Screening for lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to screening, patients should be instructed to use high sun protection factor (SPF) sun block, and cigarette smokers should be counseled to quit. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33447?source=see_link\">",
"     \"Selection of sunscreen and sun-protective measures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Neurologic events",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic complications, such as vascular damage, infections, immunosuppressive-associated leukoencephalopathy, and metabolic abnormalities, occur in 16 to 80 percent of liver transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/72-77\">",
"     72-77",
"    </a>",
"    ]. Clinical symptoms are usually mild, but major neurologic sequelae are observed in some patients.",
"   </p>",
"   <p>",
"    The development of serious neurologic events in the first month post-transplantation was evaluated retrospectively in a series of 168 liver transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/76\">",
"     76",
"    </a>",
"    ]. The most common events consisted of encephalopathy (19 percent) and seizures (5 percent). Less common complications included ischemia with seizures (related to heparin-induced thrombocytopenia), osmotic demyelination syndrome (formerly called central pontine myelinolysis), stroke, and posterior leukoencephalopathy syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10074?source=see_link\">",
"     \"Osmotic demyelination syndrome and overly rapid correction of hyponatremia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/12/17608?source=see_link&amp;anchor=H14#H14\">",
"     \"Hyponatremia in patients with cirrhosis\", section on 'Hypertonic saline, osmotic demyelination, and liver transplantation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/16/43273?source=see_link\">",
"     \"Reversible posterior leukoencephalopathy syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another series evaluated 60 patients in whom central nervous system (CNS) lesions were evident by imaging tests; the most common etiologies were [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/72\">",
"     72",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vascular events &ndash; 52 percent",
"     </li>",
"     <li>",
"      Infections &ndash; 18 percent",
"     </li>",
"     <li>",
"      Immunosuppressive associated leukoencephalopathy &ndash; 12 percent",
"     </li>",
"     <li>",
"      Osmotic demyelination syndrome &ndash; 8 percent",
"     </li>",
"     <li>",
"      Malignancy &ndash; 3 percent",
"     </li>",
"     <li>",
"      Miscellaneous &ndash; 7 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Central nervous system (CNS) lesions were detected a median of 49 days after transplantation; 75 percent were detected within 90 days of transplantation. Clinical, radiologic, and laboratory features permitted the correct diagnosis without abscess aspiration or brain biopsy in the majority of patients.",
"   </p>",
"   <p>",
"    CNS complications have been identified less frequently in patients receiving immunosuppressive regimens aimed at maintaining low blood levels of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/77\">",
"     77",
"    </a>",
"    ]. In a study of 395 such patients, major neurologic symptoms or complications were noted in 64 patients (16 percent). None of the complications were caused by infections. Complications included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       Tacrolimus",
"      </a>",
"      -related leukoencephalopathy &ndash; 0.8 percent",
"     </li>",
"     <li>",
"      Cerebrovascular disease &ndash; 4 percent",
"     </li>",
"     <li>",
"      Osmotic demyelination syndrome &ndash; 0.5 percent",
"     </li>",
"     <li>",
"      CNS symptoms with no identified cause &ndash; 11 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pretransplant variables associated with an increased risk of CNS complications included the presence of portosystemic encephalopathy, higher peak serum bilirubin levels, and lower serum cholesterol levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Hearing impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least one report suggested that hearing impairment may be common following transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/78\">",
"     78",
"    </a>",
"    ]. The most common hearing complaints in a survey of 521 transplant recipients were hearing loss (52 percent), tinnitus (38 percent), and otalgia (30 percent). An association with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    -based immunosuppression was suggested in one analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154136866\">",
"    <span class=\"h2\">",
"     Hyperuricemia and gout",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperuricemia is common in liver transplant recipients, although clinical evidence of gout occurs in only a small proportion of cases. Both cyclosporin and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    can decrease uric acid excretion.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An analysis of 134 consecutive liver transplant patients found that 47 percent had hyperuricemia and 6 percent developed gout a mean of 25 months post-transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/80\">",
"       80",
"      </a>",
"      ]. The incidence of hyperuricemia and gout was similar between patients receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      A study of 75 liver transplant recipients identified hyperuricemia in 86 percent, whereas gout developed in only 2.6 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Asymptomatic hyperuricemia is not treated in liver transplant recipients since the development of gout is uncommon. If gout does develop, treatment of the acute attack is similar to the approach used in renal transplant recipients. The acute attack is typically treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/13/32983?source=see_link\">",
"     colchicine",
"    </a>",
"    . Treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    can be considered as a second-line therapy. Nonsteroidal anti-inflammatory medications should be avoided since they can worsen renal function. Maintenance therapy is often with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    , though in patients receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    rather than the more commonly utilized antimetabolite, mycophenolic acid, the combination of azathioprine and allopurinol can lead to myelosuppression, so dose adjustments and close monitoring are required. In addition, switching from azathioprine to mycophenolic acid is an option. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/14/3303?source=see_link&amp;anchor=H2#H2\">",
"     \"Hyperuricemia and gout in renal transplant recipients\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Dermatologic complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of dermatologic conditions have been described following liver transplantation, including infections, drug-induced lesions, and conditions related to the underlying liver disease. The dermatologic complications of liver transplantation are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23273?source=see_link\">",
"     \"Dermatologic problems in patients who have undergone liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57890034\">",
"    <span class=\"h1\">",
"     HEPATOBILIARY COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatobiliary complications following liver transplantation include acute and chronic rejection, biliary complications, and recurrence of the primary liver disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57890041\">",
"    <span class=\"h2\">",
"     Acute and chronic rejection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to acute and chronic rejection following liver transplantation are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/12/30922?source=see_link\">",
"     \"Overview of immunosuppression in adult liver transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/28/37319?source=see_link\">",
"     \"Diagnosis of acute cellular rejection in liver transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41718?source=see_link\">",
"     \"Treatment of acute cellular rejection in liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57890048\">",
"    <span class=\"h2\">",
"     Biliary complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common biliary complications following liver transplantation are leaks and strictures. The approach to patients with biliary complications is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/51/826?source=see_link\">",
"     \"The role of endoscopy in biliary complications after liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57890055\">",
"    <span class=\"h2\">",
"     Recurrence of primary liver disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;A major challenge for many patients following liver transplantation is recurrence of the primary disease that caused the original liver injury. Diseases that do not recur following liver transplantation include congenital anatomic anomalies (biliary atresia, polycystic liver disease, Caroli disease, Alagille syndrome, congenital hepatic fibrosis), metabolic diseases (Wilson disease, alpha-1 antitrypsin deficiency), and acute hepatic insults (drug-induced liver failure), provided the source of injury is removed. However, all other causes of liver disease, including hepatitis B and C, primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, nonalcoholic fatty liver disease, hemochromatosis, alcohol-associated liver disease, and hepatocellular carcinoma may recur after liver transplantation and can be associated with graft injury and failure.",
"   </p>",
"   <p>",
"    The disorders most commonly associated with recurrence include hepatitis B virus (HBV) and hepatitis C virus (HCV). Fortunately, recurrence of HBV after liver transplantation can be prevented by administering",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/49/28437?source=see_link\">",
"     hepatitis B immune globulin",
"    </a>",
"    at the time of transplantation and at regular intervals thereafter, in combination with antivirals such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/55/29557?source=see_link\">",
"     entecavir",
"    </a>",
"    . Strategies to minimize or eliminate the use of hepatitis B immune globulin are evolving, including the use of \"combination\" therapy with entecavir or tenofovir and an additional agent such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/7/38007?source=see_link\">",
"     lamivudine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"     emtricitabine",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/2/15402?source=see_link&amp;anchor=H20#H20\">",
"     \"Liver transplantation for chronic hepatitis B virus infection\", section on 'Management of recurrent HBV infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By contrast, HCV recurrence following liver transplantation represents a significant source of morbidity and mortality. HCV viremia and histologic injury following transplantation is essentially universal. Although histologic injury in the allograft due to HCV is common, disease progression after the development of hepatitis is variable, with some patients experiencing indolent disease and others rapidly progressing to cirrhosis and liver failure. Treatment for recurrent HCV after transplantation is limited by toxicity, although in some patients it may be possible to achieve a sustained virologic response with peginterferon alone or in combination with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16474?source=see_link&amp;anchor=H15#H15\">",
"     \"Liver transplantation for hepatitis C virus infection\", section on 'Treatment of recurrence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In pretransplant patients, the rate of clearance of HCV has been dramatically improved by adding an HCV-directed protease inhibitor such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/6/20585?source=see_link\">",
"     telaprevir",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/40/27273?source=see_link\">",
"     boceprevir",
"    </a>",
"    to peginterferon and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    . Experience with these agents in a post-transplantation population is limited, largely due to concerns related to their effects on the pharmacokinetics of calcineurin inhibitors (CNIs) (",
"    <a class=\"graphic graphic_table graphicRef66181 \" href=\"mobipreview.htm?7/31/7664\">",
"     table 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef78070 \" href=\"mobipreview.htm?11/30/11744\">",
"     table 9",
"    </a>",
"    ). However, as experience dosing CNIs in patients receiving HCV-directed protease inhibitors increases, it is expected that response rates to therapy for HCV recurrence following liver transplantation will improve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recurrences of other diseases following liver transplantation are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/50/27430?source=see_link&amp;anchor=H7#H7\">",
"     \"Liver transplantation in primary biliary cirrhosis\", section on 'Recurrence of PBC in the transplanted liver'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/8/41097?source=see_link&amp;anchor=H20#H20\">",
"     \"Treatment of primary sclerosing cholangitis\", section on 'Liver transplantation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40058?source=see_link&amp;anchor=H25#H25\">",
"     \"Treatment of autoimmune hepatitis\", section on 'Cirrhosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5160?source=see_link&amp;anchor=H6#H6\">",
"     \"Liver transplantation in alcoholic liver disease\", section on 'Recidivism and mortality after transplantation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=see_link\">",
"     \"Liver transplantation for hepatocellular carcinoma\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H1052710303\">",
"     'Preventive medicine'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23882?source=see_link&amp;anchor=H243002891#H243002891\">",
"     \"Natural history and management of nonalcoholic fatty liver disease in adults\", section on 'Recurrence following liver transplantation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H148395519\">",
"    <span class=\"h1\">",
"     ADDITIONAL ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with end-stage liver disease may struggle with fatigue and sexual dysfunction, problems that can also be seen following liver transplantation. In addition, many women regain fertility following transplantation, so issues surrounding pregnancy also need to be addressed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H148395591\">",
"    <span class=\"h2\">",
"     Fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatigue is a major problem after liver transplantation. One of the most detailed studies included 96 transplant recipients who were followed for up to 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/83\">",
"     83",
"    </a>",
"    ]. Sixty-six percent of patients reported fatigue, while 44 percent reported severe fatigue based upon validated quality of life instruments. A decrease in health-related quality of life correlated with the severity of fatigue. Fatigue did not appear to improve with time and effective treatments for fatigue in the post-transplant setting have not been established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H148395598\">",
"    <span class=\"h2\">",
"     Sexual dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual dysfunction is common before liver transplantation and often continues afterward in men and women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32533?source=see_link\">",
"     \"Evaluation of male sexual dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25258?source=see_link\">",
"     \"Sexual dysfunction in women: Epidemiology, risk factors, and evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H148395605\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amenorrhea and decreased fertility are common among women with end-stage liver disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/26/40362/abstract/86\">",
"     86",
"    </a>",
"    ]. However, premenopausal women often regain reproductive function following liver transplantation. It is important to avoid the use of potentially teratogenic immunosuppressive agents in women of child-bearing potential who wish to become pregnant. In this circumstance, we recommend conversion from mycophenolic acid to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    , with follow-up at both the liver transplant center and with a \"high risk\" obstetrician if the patient becomes pregnant. The approach to pregnancy in women with pre-existing liver disease, including those who have undergone liver transplantation, is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/15/22777?source=see_link&amp;anchor=H16#H16\">",
"     \"Pregnancy in women with pre-existing chronic liver disease\", section on 'Liver transplantation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/34/25122?source=see_link\">",
"       \"Patient information: Liver transplant (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8234075\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Many patients are managed by primary care clinicians following liver transplantation. However, issues related to immunosuppression (including infections, organ rejection, and renal disease) and biliary complications are typically managed by a transplant hepatologist",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      surgeon. (See",
"      <a class=\"local\" href=\"#H1052710311\">",
"       'Role of the primary care clinician'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Numerous drugs interact with immunosuppressive agents, so patients should be asked about any new medications or supplements they are taking (including over the counter medications) and be reminded not to start any new medications or supplements without first speaking with their clinicians (",
"      <a class=\"graphic graphic_table graphicRef81998 \" href=\"mobipreview.htm?14/44/15042\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H154135359\">",
"       'Immunosuppression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several medical problems in addition to rejection are common following transplantation, many of which are the result of, or are made worse by, immunosuppression (",
"      <a class=\"graphic graphic_table graphicRef67917 \" href=\"mobipreview.htm?38/60/39884\">",
"       table 3",
"      </a>",
"      ). In addition to the standard treatments used in the non-transplantation population, the treatment of many of these problems may include changes in the patient's immunosuppressive regimen.",
"      <br/>",
"      <br/>",
"      Common problems include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Infections (see",
"      <a class=\"local\" href=\"#H154136303\">",
"       'Infections'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Hypertension (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Hypertension'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Diabetes (see",
"      <a class=\"local\" href=\"#H154134594\">",
"       'Diabetes mellitus'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Obesity (see",
"      <a class=\"local\" href=\"#H154134654\">",
"       'Obesity'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Dyslipidemia (see",
"      <a class=\"local\" href=\"#H154134668\">",
"       'Dyslipidemia'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Renal disease (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Acute and chronic renal disease'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Metabolic bone disease (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Metabolic bone disease'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Malignancy (see",
"      <a class=\"local\" href=\"#H14\">",
"       'De novo malignancy'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest the following screening tests for nonmalignant disease in liver transplant recipients (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H18145336\">",
"       'Screening for nonmalignant disease'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      General assessment: Annual history and physical examination, annual dental evaluations in addition to routine (twice yearly) cleanings.",
"     </li>",
"     <li>",
"      Hypertension: For the first six months following transplantation, self-monitoring every week and blood pressure monitoring by a health care provider every month. In patients without hypertension after six months, blood pressure monitoring by a health care provider every six months. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/36/32330?source=see_link&amp;anchor=H13#H13\">",
"       \"Overview of hypertension in adults\", section on 'Measurement'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diabetes mellitus: Screening every six months (typically with either a fasting plasma glucose or a hemoglobin A1C) and an annual eye examination to look for cataracts or diabetic changes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/16/2312?source=see_link&amp;anchor=H13#H13\">",
"       \"Screening for diabetes mellitus\", section on 'A suggested approach'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dyslipidemia: Annual fasting lipid profile. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31222?source=see_link\">",
"       \"Measurement of serum lipids and lipoproteins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cardiovascular disease: We perform stress testing every three to five years in patients with risk factors for coronary artery disease and more frequently in patients with pre-existing coronary artery disease. Exercise stress testing is preferred for those who are able to do the test. For those unable to do exercise stress testing, adenosine and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress tests are alternatives. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26521?source=see_link\">",
"       \"Stress testing for the diagnosis of coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Renal disease: During the first year, urinalysis, microalbumin, and determination of the",
"      <span class=\"nowrap\">",
"       creatinine/glomerular",
"      </span>",
"      filtration rate every two to three months. After the first year, we obtain the tests every six months. (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/60/35785?source=see_link&amp;anchor=H12#H12\">",
"       \"Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease\", section on 'Assessment of kidney function'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Metabolic bone disease: Bone mineral density measurement prior to transplantation and every other year after transplantation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42583?source=see_link\">",
"       \"Overview of dual-energy x-ray absorptiometry\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest the following screening tests for malignant disease in liver transplant recipients (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H18145343\">",
"       'Screening for malignancies'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Annual physical examination including examination of the oropharynx and a full body dermatologic examination.",
"     </li>",
"     <li>",
"      Annual urinalysis.",
"     </li>",
"     <li>",
"      Annual prostate specific antigen measurement in men.",
"     </li>",
"     <li>",
"      Annual Papanicolaou smear and mammography in women.",
"     </li>",
"     <li>",
"      Annual abdominal magnetic resonance imaging (MRI) in patients with recurrent viral hepatitis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      in patients who were transplanted for hepatocellular carcinoma or were found to have hepatocellular carcinoma in their explanted liver. However, for patients with recurrent viral hepatitis, some centers reserve hepatocarcinoma surveillance for patients who progress to bridging fibrosis or cirrhosis, which is a reasonable alternative.",
"     </li>",
"     <li>",
"      Colonoscopy three years after liver transplantation (one year if there is a history of adenoma or inflammatory bowel disease), followed by colonoscopy every three to five years, unless indicated sooner based upon the patient's history.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients receiving solid organ transplantations should be vaccinated for, among other things, influenza, pneumonia, and hepatitis A and B (",
"      <a class=\"graphic graphic_table graphicRef61599 \" href=\"mobipreview.htm?13/52/14157\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/48/23306?source=see_link\">",
"       \"Immunizations in solid organ transplant candidates and recipients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infection is the leading cause of mortality following liver transplantation and patients who develop a fever or other signs of infection require urgent evaluation, because even common infections can rapidly progress to sepsis with multiorgan failure (",
"      <a class=\"graphic graphic_table graphicRef75619 \" href=\"mobipreview.htm?29/47/30459\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H154136303\">",
"       'Infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach to immunosuppression, issues related to acute and chronic rejection following liver transplantation, biliary complications of liver transplantation, and recurrent liver disease following transplantation are discussed in detail elsewhere.",
"      <br/>",
"      <br/>",
"      See:",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/12/30922?source=see_link\">",
"       Overview of immunosuppression in adult liver transplantation",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/28/37319?source=see_link\">",
"       Diagnosis of acute cellular rejection in liver transplantation",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41718?source=see_link\">",
"       Treatment of acute cellular rejection in liver transplantation",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/51/826?source=see_link\">",
"       The role of endoscopy in biliary complications after liver transplantation",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16474?source=see_link\">",
"       Liver transplantation for hepatitis C virus infection",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/2/15402?source=see_link\">",
"       Liver transplantation for chronic hepatitis B virus infection",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/50/27430?source=see_link\">",
"       Liver transplantation in primary biliary cirrhosis",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/8/41097?source=see_link\">",
"       Treatment of primary sclerosing cholangitis",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40058?source=see_link\">",
"       Treatment of autoimmune hepatitis",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23882?source=see_link\">",
"       Natural history and management of nonalcoholic fatty liver disease in adults",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5160?source=see_link\">",
"       Liver transplantation in alcoholic liver disease",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=see_link\">",
"       Liver transplantation for hepatocellular carcinoma",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/1\">",
"      McCashland TM. Posttransplantation care: role of the primary care physician versus transplant center. Liver Transpl 2001; 7:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/2\">",
"      Faure S, Herrero A, Jung B, et al. Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication. J Hepatol 2012; 57:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/3\">",
"      Lucey MR. Liver transplantation in patients with alcoholic liver disease. Liver Transpl 2011; 17:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/4\">",
"      Torbenson M, Wang J, Nichols L, et al. Causes of death in autopsied liver transplantation patients. Mod Pathol 1998; 11:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/5\">",
"      Chang FY, Singh N, Gayowski T, et al. Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis 1998; 26:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/6\">",
"      Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338:1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/7\">",
"      Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011; 17:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/8\">",
"      Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol 2010; 53:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/9\">",
"      Stegall MD, Everson G, Schroter G, et al. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation 1995; 60:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/10\">",
"      Textor SC, Canzanello VJ, Taler SJ, et al. Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 1994; 69:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/11\">",
"      Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving &gt; or = 5 years after liver transplant. Transplantation 2000; 69:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/12\">",
"      Taler SJ, Textor SC, Canzanello VJ, et al. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. Am J Hypertens 1995; 8:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/13\">",
"      Textor SC, Canzanello VJ, Taler SJ, et al. Hypertension after liver transplantation. Liver Transpl Surg 1995; 1:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/14\">",
"      Mangray M, Vella JP. Hypertension after kidney transplant. Am J Kidney Dis 2011; 57:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/15\">",
"      Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet 1994; 344:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/16\">",
"      A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994; 331:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/17\">",
"      Canzanello VJ, Textor SC, Taler SJ, et al. Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506). Liver Transpl Surg 1998; 4:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/18\">",
"      Stegall MD, Wachs ME, Everson G, et al. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Transplantation 1997; 64:1755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/19\">",
"      Penninga L, M&oslash;ller CH, Gustafsson F, et al. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol 2010; 66:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/20\">",
"      Neal DA, Tom BD, Luan J, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004; 77:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/21\">",
"      Bigam DL, Pennington JJ, Carpentier A, et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000; 32:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/22\">",
"      Navasa M, Bustamante J, Marroni C, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/23\">",
"      AlDosary AA, Ramji AS, Elliott TG, et al. Post-liver transplantation diabetes mellitus: an association with hepatitis C. Liver Transpl 2002; 8:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/24\">",
"      Saab S, Shpaner A, Zhao Y, et al. Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation. Am J Transplant 2006; 6:1890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/25\">",
"      Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004; 4:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/26\">",
"      Haddad EM, McAlister VC, Renouf E, et al. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 2006; :CD005161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/27\">",
"      Trail KC, McCashland TM, Larsen JL, et al. Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. Liver Transpl Surg 1996; 2:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/28\">",
"      Moon JI, Barbeito R, Faradji RN, et al. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation 2006; 82:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/29\">",
"      Stegall MD, Everson GT, Schroter G, et al. Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss. Hepatology 1997; 25:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/30\">",
"      Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005; 19:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/31\">",
"      Dumortier J, Bernard S, Bouffard Y, Boillot O. Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus. Liver Transpl 2006; 12:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/32\">",
"      Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/33\">",
"      Bianchi G, Marchesini G, Marzocchi R, et al. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl 2008; 14:1648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/34\">",
"      Everhart JE, Lombardero M, Lake JR, et al. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg 1998; 4:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/35\">",
"      Munoz SJ, Deems RO, Moritz MJ, et al. Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant Proc 1991; 23:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/36\">",
"      Canzanello VJ, Schwartz L, Taler SJ, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/37\">",
"      Neal DA, Gimson AE, Gibbs P, Alexander GJ. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Liver Transpl 2001; 7:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/38\">",
"      Campsen J, Zimmerman M, Shoen J, et al. Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obes Surg 2008; 18:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/39\">",
"      Liu LU, Schiano TD. Long-term care of the liver transplant recipient. Clin Liver Dis 2007; 11:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/40\">",
"      Mu&ntilde;oz SJ. Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: pathogenesis, diagnosis, and management. Liver Transpl Surg 1995; 1:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/41\">",
"      Gisbert C, Prieto M, Berenguer M, et al. Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg 1997; 3:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/42\">",
"      Moench C, Barreiros AP, Schuchmann M, et al. Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. Am J Transplant 2007; 7:1616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/43\">",
"      Manzarbeitia C, Reich DJ, Rothstein KD, et al. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients. Liver Transpl 2001; 7:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/44\">",
"      Roy A, Kneteman N, Lilly L, et al. Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. Transplantation 2006; 82:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/45\">",
"      McCune TR, Thacker LR II, Peters TG, et al. Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. Transplantation 1998; 65:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/46\">",
"      Almutairi F, Peterson TC, Molinari M, et al. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Liver Transpl 2009; 15:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/47\">",
"      Savvidaki E, Koukoulaki M, Benou A, et al. Ezetimibe is effective in the treatment of persistent hyperlipidemia of renal allograft recipients. Clin Nephrol 2011; 75:107.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/medeff/advisories-avis/prof/2005/ezetrol_hpc-cps-eng.pdf (Accessed on January 11, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/49\">",
"      Madhwal S, Atreja A, Albeldawi M, et al. Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies. Liver Transpl 2012; 18:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/50\">",
"      Albeldawi M, Aggarwal A, Madhwal S, et al. Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl 2012; 18:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/51\">",
"      Johnston SD, Morris JK, Cramb R, et al. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/52\">",
"      Fouad TR, Abdel-Razek WM, Burak KW, et al. Prediction of cardiac complications after liver transplantation. Transplantation 2009; 87:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/53\">",
"      Pruthi J, Medkiff KA, Esrason KT, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001; 7:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/54\">",
"      Vogt DP, Henderson JM, Carey WD, Barnes D. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/55\">",
"      de Kroon L, Drent G, van den Berg AP, et al. Current health status of patients who have survived for more than 15 years after liver transplantation. Neth J Med 2007; 65:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/56\">",
"      Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/57\">",
"      Corman SL, Coley KC, Schonder KS. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients. Pharmacotherapy 2006; 26:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/58\">",
"      Millis JM, McDiarmid SV, Hiatt JR, et al. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation 1989; 47:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/59\">",
"      Marotta PJ. Renal-sparing protocols in liver transplantation. Liver Transplant 2009; 15(Suppl 2):S14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/60\">",
"      Klintmalm GB, Gonwa TA. Nephrotoxicity associated with cyclosporine and FK506. Liver Transpl Surg 1995; 1:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/61\">",
"      Manzia TM, De Liguori Carino N, Orlando G, et al. Use of mycophenolate mofetil in liver transplantation: a literature review. Transplant Proc 2005; 37:2616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/62\">",
"      Neff GW, Montalbano M, Slapak-Green G, et al. Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. Transplant Proc 2003; 35:3029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/63\">",
"      Ladefoged SD, Andersen CB. Calcium channel blockers in kidney transplantation. Clin Transplant 1994; 8:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/64\">",
"      Haagsma EB, Thijn CJ, Post JG, et al. Bone disease after orthotopic liver transplantation. J Hepatol 1988; 6:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/65\">",
"      Watt KD, Pedersen RA, Kremers WK, et al. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology 2009; 137:2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/66\">",
"      Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/67\">",
"      Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int 2010; 30:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/68\">",
"      Higashi H, Yanaga K, Marsh JW, et al. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990; 11:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/69\">",
"      Duvoux C, Delacroix I, Richardet JP, et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/70\">",
"      Finkenstedt A, Graziadei IW, Oberaigner W, et al. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant 2009; 9:2355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/71\">",
"      Herrero JI, Alegre F, Quiroga J, et al. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clin Transplant 2009; 23:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/72\">",
"      Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation 1998; 66:1596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/73\">",
"      Adams DH, Ponsford S, Gunson B, et al. Neurological complications following liver transplantation. Lancet 1987; 1:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/74\">",
"      Singh N, Yu VL, Gayowski T. Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine (Baltimore) 1994; 73:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/75\">",
"      Ferreiro JA, Robert MA, Townsend J, Vinters HV. Neuropathologic findings after liver transplantation. Acta Neuropathol 1992; 84:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/76\">",
"      Saner FH, Sotiropoulos GC, Gu Y, et al. Severe neurological events following liver transplantation. Arch Med Res 2007; 38:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/77\">",
"      Vizzini G, Asaro M, Miraglia R, et al. Changing picture of central nervous system complications in liver transplant recipients. Liver Transpl 2011; 17:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/78\">",
"      Rifai K, Kirchner GI, Bahr MJ, et al. A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation. Liver Transpl 2006; 12:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/79\">",
"      Rifai K, Bahr MJ, Cantz T, et al. Severe hearing loss after liver transplantation. Transplant Proc 2005; 37:1918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/80\">",
"      Neal DA, Tom BD, Gimson AE, et al. Hyperuricemia, gout, and renal function after liver transplantation. Transplantation 2001; 72:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/81\">",
"      Shibolet O, Elinav E, Ilan Y, et al. Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study. Transplantation 2004; 77:1576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/82\">",
"      Garg V, van Heeswijk R, Lee JE, et al. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus. Hepatology 2011; 54:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/83\">",
"      van den Berg-Emons R, van Ginneken B, Wijffels M, et al. Fatigue is a major problem after liver transplantation. Liver Transpl 2006; 12:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/84\">",
"      Sorrell JH, Brown JR. Sexual functioning in patients with end-stage liver disease before and after transplantation. Liver Transpl 2006; 12:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/85\">",
"      Ho JK, Ko HH, Schaeffer DF, et al. Sexual health after orthotopic liver transplantation. Liver Transpl 2006; 12:1478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/26/40362/abstract/86\">",
"      Christopher V, Al-Chalabi T, Richardson PD, et al. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl 2006; 12:1138.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4589 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-222.169.60.2-DB8828736C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40362=[""].join("\n");
var outline_f39_26_40362=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8234075\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1052710311\">",
"      ROLE OF THE PRIMARY CARE CLINICIAN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1052710303\">",
"      PREVENTIVE MEDICINE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18145336\">",
"      Screening for nonmalignant disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18145343\">",
"      Screening for malignancies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18145432\">",
"      Immunizations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H75299348\">",
"      Recommendations regarding alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H154135359\">",
"      IMMUNOSUPPRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H154134134\">",
"      COMPLICATIONS OF IMMUNOSUPPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H154136303\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H154134169\">",
"      Metabolic syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      - Hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H154134594\">",
"      - Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H154134654\">",
"      - Obesity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H154134668\">",
"      - Dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H154134702\">",
"      - Cardiovascular risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute and chronic renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Metabolic bone disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      De novo malignancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H69198694\">",
"      - Incidence of de novo malignancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H69198615\">",
"      - Screening and prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Neurologic events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Hearing impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H154136866\">",
"      Hyperuricemia and gout",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Dermatologic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H57890034\">",
"      HEPATOBILIARY COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H57890041\">",
"      Acute and chronic rejection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H57890048\">",
"      Biliary complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H57890055\">",
"      Recurrence of primary liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H148395519\">",
"      ADDITIONAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H148395591\">",
"      Fatigue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H148395598\">",
"      Sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H148395605\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8234075\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4589\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4589|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?21/3/21567\" title=\"diagnostic image 1\">",
"      PCP of liver after OLT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4589|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/18/20778\" title=\"figure 1\">",
"      Standard alcoholic drink PI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/33/22035\" title=\"figure 2\">",
"      Infection timeline SOT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/21/36190\" title=\"figure 3\">",
"      Incidence of CKD after nonrenal organ TPL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/42/38573\" title=\"figure 4\">",
"      Cyclosporine and Ca blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/34/10797\" title=\"figure 5\">",
"      BMD after liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4589|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/44/15042\" title=\"table 1\">",
"      Drug interactions with immunosuppressants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/52/14157\" title=\"table 2\">",
"      Vaccines solid organ transplant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/60/39884\" title=\"table 3\">",
"      Immunosuppressive agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/47/30459\" title=\"table 4\">",
"      Evaluation fever after OLT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/44/31437\" title=\"table 5\">",
"      Definition metabolic syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/36/5708\" title=\"table 6\">",
"      Pharmacologic agents HTN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/10/44205\" title=\"table 7\">",
"      Rx hyperlipidemia after OLT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/31/7664\" title=\"table 8\">",
"      Boceprevir drug interactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/30/11744\" title=\"table 9\">",
"      Telaprevir drug interactions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24790?source=related_link\">",
"      Acute cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32746?source=related_link\">",
"      Approach to the patient with colonic polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/47/35578?source=related_link\">",
"      Approach to the patient with hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/28/15816?source=related_link\">",
"      Behavioral strategies in the treatment of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/2/29737?source=related_link\">",
"      Blood pressure management in patients with atherosclerotic cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/63/22521?source=related_link\">",
"      Clinical manifestations and diagnosis of primary sclerosing cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/25/40342?source=related_link\">",
"      Colorectal cancer and primary sclerosing cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/7/25722?source=related_link\">",
"      Colorectal cancer surveillance in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23273?source=related_link\">",
"      Dermatologic problems in patients who have undergone liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34170?source=related_link\">",
"      Development of malignancy following solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/28/37319?source=related_link\">",
"      Diagnosis of acute cellular rejection in liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/25/8597?source=related_link\">",
"      Diagnosis of cytomegalovirus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/60/35785?source=related_link\">",
"      Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/38/25194?source=related_link\">",
"      Epidemiology and etiologic associations of hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37832?source=related_link\">",
"      Epidemiology and risk factors for skin cancer in solid organ transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32533?source=related_link\">",
"      Evaluation of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/46/34537?source=related_link\">",
"      Evidence-based approach to prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/55/15225?source=related_link\">",
"      General principles of insulin therapy in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16761?source=related_link\">",
"      Hypertension after renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/14/3303?source=related_link\">",
"      Hyperuricemia and gout in renal transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/12/17608?source=related_link\">",
"      Hyponatremia in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/48/23306?source=related_link\">",
"      Immunizations in solid organ transplant candidates and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/47/29433?source=related_link\">",
"      Infection in the solid organ transplant recipient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16842?source=related_link\">",
"      Infectious complications in liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43577?source=related_link\">",
"      Initial management of blood glucose in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/54/29546?source=related_link\">",
"      Lipid abnormalities after renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=related_link\">",
"      Lipid lowering with drugs other than statins and fibrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/2/15402?source=related_link\">",
"      Liver transplantation for chronic hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16474?source=related_link\">",
"      Liver transplantation for hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=related_link\">",
"      Liver transplantation for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5160?source=related_link\">",
"      Liver transplantation in alcoholic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/50/27430?source=related_link\">",
"      Liver transplantation in primary biliary cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31222?source=related_link\">",
"      Measurement of serum lipids and lipoproteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/8/29830?source=related_link\">",
"      Metabolic bone disease in primary biliary cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/33/39449?source=related_link\">",
"      Microalbuminuria in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23882?source=related_link\">",
"      Natural history and management of nonalcoholic fatty liver disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/40/26250?source=related_link\">",
"      New onset diabetes after transplant (NODAT) in renal transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10074?source=related_link\">",
"      Osmotic demyelination syndrome and overly rapid correction of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/55/29561?source=related_link\">",
"      Osteoporosis after solid organ or stem cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42583?source=related_link\">",
"      Overview of dual-energy x-ray absorptiometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/36/32330?source=related_link\">",
"      Overview of hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/12/30922?source=related_link\">",
"      Overview of immunosuppression in adult liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37962?source=related_link\">",
"      Overview of preventive medicine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/3/23609?source=related_link\">",
"      Overview of smoking cessation management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38874?source=related_link\">",
"      Overview of the risks and benefits of alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/34/25122?source=related_link\">",
"      Patient information: Liver transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=related_link\">",
"      Pharmacology and side effects of cyclosporine and tacrolimus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/15/22777?source=related_link\">",
"      Pregnancy in women with pre-existing chronic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/28/34250?source=related_link\">",
"      Renal function and nonrenal solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/16/43273?source=related_link\">",
"      Reversible posterior leukoencephalopathy syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/20/12615?source=related_link\">",
"      Screening for and clinical evaluation of obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/41/9881?source=related_link\">",
"      Screening for colorectal cancer: Strategies in patients with possible increased risk due to family history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/16/2312?source=related_link\">",
"      Screening for diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/58/28586?source=related_link\">",
"      Screening for lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33447?source=related_link\">",
"      Selection of sunscreen and sun-protective measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=related_link\">",
"      Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25258?source=related_link\">",
"      Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/35/32314?source=related_link\">",
"      Statins: Actions, side effects, and administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26521?source=related_link\">",
"      Stress testing for the diagnosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/58/2986?source=related_link\">",
"      Stress testing to determine prognosis and management of patients with known or suspected coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/31/33274?source=related_link\">",
"      Surgical management of severe obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/61/28634?source=related_link\">",
"      Surveillance after colorectal cancer resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/51/826?source=related_link\">",
"      The role of endoscopy in biliary complications after liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41718?source=related_link\">",
"      Treatment of acute cellular rejection in liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40058?source=related_link\">",
"      Treatment of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/45/21210?source=related_link\">",
"      Treatment of hypertension in patients with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/32/14856?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in primary prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26122?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in secondary prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/8/41097?source=related_link\">",
"      Treatment of primary sclerosing cholangitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_26_40363="MGUS cytogenic changes";
var content_f39_26_40363=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F52114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F52114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Primary cytogenetic changes in monoclonal gammopathy of undetermined significance (MGUS)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Cytogenetic abnormality",
"       </td>",
"       <td class=\"subtitle1\">",
"        Approximate percent of MGUS",
"       </td>",
"       <td class=\"subtitle1\">",
"        Genes dysregulated by cytogenetic changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Primary IgH translocations involving chromosome 14q32 (non-hyperdiploid MGUS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(11;14)(q13;q32)",
"       </td>",
"       <td>",
"        25 percent",
"       </td>",
"       <td>",
"        CCND1 (cyclin D1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(4;14)(p16;q32)",
"       </td>",
"       <td>",
"        15 percent",
"       </td>",
"       <td>",
"        FGFR-3 and MMSET",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(14;16)(q32;q23)",
"       </td>",
"       <td>",
"        5 percent",
"       </td>",
"       <td>",
"        C-MAF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(6;14)(p21;q32)",
"       </td>",
"       <td>",
"        3 percent",
"       </td>",
"       <td>",
"        CCND3 (cyclin D3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(14;20)(q32;q11)",
"       </td>",
"       <td>",
"        2 percent",
"       </td>",
"       <td>",
"        MAFB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Hyperdiploidy (hyperdiploid MGUS)",
"        </strong>",
"       </td>",
"       <td>",
"        45 percent",
"       </td>",
"       <td>",
"        Multiple genes dysregulated due to recurrent trisomies involving odd-numbered chromosomes with exception of chromosomes 1, 13, and 21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Unknown",
"        </strong>",
"       </td>",
"       <td>",
"        &lt;5 percent",
"       </td>",
"       <td>",
"        Neither IgH translocation nor hyperdiploidy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40363=[""].join("\n");
var outline_f39_26_40363=null;
var title_f39_26_40364="High-risk patients with neutropenic fever";
var content_f39_26_40364=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67027&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67027&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Patients with neutropenic fever who are at high risk for serious complications",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Patients with",
"        <strong>",
"         any",
"        </strong>",
"        of the following characteristics are considered to be at high risk for serious complications during episodes of neutropenic fever:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neutropenia (absolute neutrophil count &lt;500 cells/microL) anticipated to last &gt;7 days*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Presence of any comorbid medical problems, including, but not limited to:",
"        <ul>",
"         <li>",
"          Hemodynamic instability",
"         </li>",
"         <li>",
"          Oral or gastrointestinal mucositis that interferes with swallowing or causes severe diarrhea",
"         </li>",
"         <li>",
"          Gastrointestinal symptoms, including abdominal pain, nausea and vomiting, or diarrhea",
"         </li>",
"         <li>",
"          Neurologic or mental status changes of new onset",
"         </li>",
"         <li>",
"          Intravascular catheter infection, especially catheter tunnel infection",
"         </li>",
"         <li>",
"          New pulmonary infiltrate or hypoxemia",
"         </li>",
"         <li>",
"          Underlying chronic lung disease",
"         </li>",
"         <li>",
"          Complex infection at the time of presentation",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alemtuzumab use within the past two months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inpatient status at the time of development of fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Uncontrolled or progressive cancer",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Evidence of hepatic insufficiency (defined as aminotransferase levels &gt;5 times normal values) or renal insufficiency (defined as a creatinine clearance of &lt;30 mL/min)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Multinational Association for Supportive Care in Cancer (MASCC) risk index score &lt;21",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The authors consider patients with an absolute neutrophil count &lt;500 cells/microL for &gt;7 days to be at high risk for serious complications. It should be noted that in the Infectious Diseases Society of America, the National Comprehensive Cancer Network, and the American Society of Clinical Oncology guidelines, patients with an absolute neutrophil count &le;100 cells/microL for &gt;7 days are considered to be at high risk for serious complications",
"     <sup>",
"      [1,2,3]",
"     </sup>",
"     .",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Defined as any leukemic patient not in complete remission or a non-leukemic patient with evidence of disease progression after more than two courses of chemotherapy.",
"     <br/>",
"     &Delta; See the associated topic review for details about the MASCC risk index.",
"    </div>",
"    <div class=\"reference\">",
"     Data adapted from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52:e56.",
"      </li>",
"      <li>",
"       National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Prevention and treatment of cancer-related infections. Version 1.2012. file://www.nccn.org (Accessed on January 03, 2013).",
"      </li>",
"      <li>",
"       Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40364=[""].join("\n");
var outline_f39_26_40364=null;
var title_f39_26_40365="Diurnal testosterone pattern";
var content_f39_26_40365=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F80568&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F80568&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diurnal pattern of testosterone secretion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 269px; background-image: url(data:image/gif;base64,R0lGODlhkQENAdUAAP///4CAgAAAAAAzmYCZzP8AAMDAwEBAQODg4PDw8KCgoMDN5iAgIDAwMKCz2fDz+RBAn/9gYP+goEBms5CQkGCAv7CwsFBQUBAQEP/w8NDQ0HBwcP8QECBNpv8gIP+AgP9AQFBzuf8wMGBgYP/AwDBZrNDZ7ODm83CNxv/Q0P9QULDA3/+wsP/g4P+QkP9wcJCm0wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACRAQ0BAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2RCQoBFAmepaanTQkNAgcCGKSosbKmBgINAK0Gs7u8mKq2DCNDBgHFxrq9ycqECSMYDLawxMYBBwHL2Nl8FALXF91Ixdrj5HMKtgarCuHX5e7vahsYAgztR+Lw+fpv+Pv+/2X6ARxIcIvAgggTRjmosKHDe/YeSpzIcKJFhBUvavyXcaNHeB0/ihwXcqRJZSVPqpyVcqVLUy1fytwUc6ZNSzVv6oyUc6dP/0Y9fwo9FHSoUUFFjyrVM83a0qeJmkaE2mnBghNCTFx9mJQqIwIDJgB4AAHCA65TvWp60GHACrAwxqKYUMGEEAIO7ubFC4PuWQAEJqDAWwRvYAcmQoT462DChLgnCKyYS6BRxQUEMi9QawhzZgKbjawY0LaEkBIQCKDGGlZI6wEDSrStAADFgBBgxRKBjZp0iQG0baMIMQDGAtgTIAzIu6giWNiVORN6Dh3JBNh2TQxAAWB03NYAXot98LqDa91DWoPd3BpCh8xhj1ceHV2Rc9gD6ksPRD0/kuO6yQeAgOCJd154uoGXnljrIRjee5k5IKCAzaUFGH767fdHBfj5d/8EgEO4twBxdimHAodiFSjWbys4oOCBDbZGHGgOgOYfhfZZSF2GGvLBYYc8CgFiVr91wJwDZdmWYoJimdDWdejBOAB741WgXGoTepjjhwRwGFqPfVRQQo2ffQnGAitgtl0vIXVgF5h7PDBBCX+d4eIAEFRQJ0sWDnEinHo8UMIEe8oUkgkQAIrHCSXQtlNJJaygaB2IOvpon0PAEMKkcXiWp1AlnTBAoZyqsSOomA4RQlyltmFbdf8gEAACX6TkgGmtrnEnrP7UgkwXLUGAVa5ouPgbr/v4WmuqQ1TAHbFmuChhmflQE8AIAvzKRUsLmActGdIOJMC45Ga7rBMdmPn/rRfhDmRtMbQ+kYAB9NILixEx/bnuF+2+VEu52hIR0wlm7dtFvwVNAy8U8xpwjgDx4sssEWMajIVnwin0MLkBO4GtMEIoXIxTTjiwqcVW9BckRwJYUO+9TyAwbsQiVzPxEOQNi/IUKiuEAAYRT/GxEjmtujMVPyJL0C8cR/Fv0BJDsQKuR0Nh5WegKRSALQd0rUEUrWywRE8QvFl1E2Lq7NA5ZPTk7NlMyEmnRT+PYAzUWvSEKNxKCEroRf827UVQHUjKtxGMWmpRwy+fGwUMih8OQKWT9rQAh5rx7WnkElmwTkA3E9Ez3KdqtDUGG+ANbOhDjF61A20pPZEB2Nqi/wDM27J+F5Cvd9DBdbIvTsEqGIzw9epReDaouuvCbuSA1JqkgTMHDK47ESZD4VnmS21PgO/M3TSv9VSQR2oSrh/VH+cnMU6v6lh0FUL4TKy/1APEYThT4OSKjTwV2XNCf0hDv52cAAVl4Z1MDFCPa2HgG/CrQlfM54Ru4YZG4NuJCThUF+8x7yQUqJ4QsmWu3Flhfk4QVaGch7UPXmR7yUGB2nbCDQoQg4Qdu0JXABBAJujLCLDT30ios5ijJGAe42qABiD2v/KNKm7CQp8QRVI6I1IgALcDww4BgMIl9EUJ1GHfRapoFPfhLm/XA+LJlFA4JWzvUyJxEfeM8jOAOf+uChRMAuyekDiRrCBKR9naBe7GBalgoYvWKeAS/Ha+hwwGKmwDgyGv0EMjIKqRSZAbJhUyARf+5GcKaBz5rpBHI1RgZUxIm0ae+BT+lbCJJ1QkAEQ1Q6uVzSILoNpSZEWNCFphi0KoZOvE+ISrzTEhXZJc1LBQSiGQxZMCVKBCEKlMIQBTCNTkISB5Js2ERLGaQ7gmD9cohOddIX0FIRg4BZZGJJSyW1nwzATS1RBhUiUUvpRgO5GAyMdw4ZINOeV+cnFHLASQYJucQsUUUgJoHkUDBjhjFsQ5lidWgJhVuJVCyMMZBFAglBTQ4j756YCceYEsZiPIAraplDoeYIn/+aQCRQFTghDQ0wsXHYMHLUGAZ1GFAhioBgBeacItkHELAA0DOiMxAcNRpRoGOIDMchi/kR7hqFtYKBiWCokB1FIptbgAAxqAAZFyAata0CgY8NfNSDhJOrUTwOdGqQW0ZgGlXjhgAqcoCcjtBwERDcNMt+dQK+TUCoTdIHC08pnUVKICrFKLyGI6hZmaIalUoE6SarmCgk3CTZxxJVV1aNU2aJWbsCkiP8n5CFFJZ2s2tFdB/6DWzPLVCGRx6iP+KB0LCOAKoOiIZc2AVyrkT0tI6GxCDfHIjhaPkFDQwDwOwIAkDNcMh5VCZ6OnBMUwtbBCEW0UoHE865a2DZh9/0JuobDeR7BSLe4L7BOWyABoXGAY1iLZIE7rBO9GQbmOyKWGgmsBKdSiAemQa8jye9421NYJAJaCf7+CUSOuYlwgmy8rALC1Pl2XuLd0QnulMGJFZPOnGAjl1srrBGhYYBVU/TB2J3DM1VphuzUmxDc5I9QRjhYJGiDeXJc5nduKxrNVOC4q/6DO/fjWbq2QaFUNYVdnQkC3tg1eIOzplbgOuahFTi0mJ5wyIwtCoD0CrJQn2uA2aBYCMjzycptQ5T80VEPKEoOMy5BYDjI2M46NZ2DunAfCunMAPTrij9ncCL0qx8xVgKce7LrSHmmgvl176WwVwVZIV6GNebBrT/97JF66NoKrKavwG6jT1CO0ep3sgASqq6DCUONnnnBOqVfBZIELbKDXZn3ETrtw4jlM4IKbMQECIWSbrO1niayQGYsN0mZNPJgO6R3CH9vqlQAwwALVIyq18xHiOrwNCbNeSgAQfIBaTBuN+Tg3HWgpRU/vkh4YeEaw37G3Ovzwqtz2igKgocR9vwPUcijuf1o4YGSMb9Pk0BQdAmOxWgxB3PDORzPfcNN1bWAVXYMxxMlhtDjs0WCtKJcITf2OFXgLDuY0mAZWLthqd6LcbZC0xWSFAAW0uwuTNEIEChCBbPybDTTemQKANq6yFnJkfSqA1LPRb/Qi2WDV8K1vFy3/06hPPRv8TYO8LUaBYPwW44w+wtA58IFscNkM9N6ZS31LWSmEJAUcIAE2TLrwHLuRu0Y4esUDkAALhHTkQ5AABzJAhqEXnRBoBriW0Q1phe+MwDVnQgRUMIYMSL0AhXA5EoIo5pLFjjQVWMFfPBMCCIC3VEwTQIZhiYQMeMAFYlDB5w3R8WD6Dnh4gvNXh+A84J/yNyXoUsDXBVQVC+DdaV9CCgqQAjCwgANrbzshfui8vWBIsXUBYgZL94AVVOD0yLVYj4fK9cqGzgUeYHwXMsABFggB73oXxOVS872YG3qWCERjn5FBQgJ4F2JvxPJk1SAAa/ZLrKMCj8cFKsB5/4m3eIJgP03QabChaq2zfJTQAh/wARIwBC8AAkUgASBQfZLgZQa3BPQ3gltwffI3BJt3gR5oBOlWBMOWCRJQAB4gAgUgAowHAqBHBB9QAPknCWqWeU9AAhygglhAf/ZXBLaHe4CQg6Jzg5pwhAWgfUXQAj7IeC5AdABAhPenAiBAhEkIABLwASwAAi+QARGQgkLQAnMYAdXXhiwwgVBIBzMnBAkgVYiHBB8gAlowgUgwfX3IB1jYgQiYCZ9XhEUwhi8gBJ7HAWUIei3AAWynhkRAhB7gAQXAAaAIAJsoAh/AiZn4gz5oBxrADfSydYOIBHCIBTKYBPA3g3ywg0zAi/+ekAFc+HVFcIReOHVmOIYjeIRraIYk0IWZCABjGAEfoIZmCABAaAcpVy51txBp9AJS54VSIIVLAIFh4HiGwIXgiAXmyAYt8AKkOHTOaAQsUAAUOH2GaIbKCAD5OATM6Iz4SHQh+AEtUI3VSAcKgC3H0IJNEIlVgIguyAEwyAUSIIpS5wERwAK66AcMqQVgKIxokAKOt4hIAIRuCIT2148qQAKeyI+g14xtZ4b2yAIk8AIpQJCSSAeykgAaMCsKyQQbKQW3yAROKJJEsI5MMJEe0INSRwKFGIQfwJTfuAeRGJFWkAFAKHVW2Hj0CAIc8AIt8ARyyAFBOIXV6I0cAIT/y9iS/liELHCVIjCQRViQdEB383ALs3gEXOgBUyCOTlCISdCMUpeRRoCUMGiUGcACEUCRHnkHV6l7VEkFd0iP2FcGn/cBgkkS7dYNz3eXSZCUUuCQT1CLQkACLhABQHiVFQkCbtiHhOkEP3kHJKCXQtCDjxkFijeDLSACEfgFE7l7+rBuW5MAaDdlVDCRUACPu9kE8CiKuukC+WeOKcAC08icn1ebSsCFFIgHqkkEtEkF+EeFIgACl3kFhGmU8ABtDLBE0EecVOCZrumbT/CaTOB58AkF0/eVsGmB3FkA1umCt3cEGQACQrgFrUkQIfSK9+U09TJaO2ScTkCRyal5/1IXoUuAnFTwAtlZB9s5mPwZBaCpdm9ZBVyYmO6JEBqgAQiwnkpQLr8Va1ZQotc5oH9Af2soB3g3nt3pBLlYoU9IBVOpEL9wAL7VgEcwLvViXuQpm0owlILgoHQgjUqQo0vApEzgAj0qBfJJEOdwAeHWfkQwLgdwAb9SM/pVBTBqBC9ICKhIB2A4nokndYaYBGnqBERIhlBQp+lIEFB1AMLppUMwSNgCNAtGDWVanEp6BB8aCE7opmoQARRqBJ9nkRhpBCDwqEiQpUuqnw2xdOuGLUSaBAQFEVlwpkOwo4XgqHIAhvi5BKfJlKf5lHnJqEJXkWD5nxJxYQLgP0+QDv/X4gpSdk1OSgSKeAg0GgeoupeIqZg3CZb15wQluDihUGBRgAAXVnAuigVnWoWJ4Jdv4HmrWgWY2gRBmanfqhDg0DZtFqwAMIeLQKpp8AGWCgXo2JAZOpJZ6RDnOgYUVaK3uQiL2gb0R5RrwJeEGKcSQQ+Z5jWc6QQO+p2MoAKVyAbTSAfjWgTDOhEsaqQL+6AjuKaNAIYC23l5VweJOgQei7EjsKDyRXtJ+gIG2wgTqwYxSwcEW6ove7A2h6RcAKeQQJ832wSn2Z41KgcVu4lD6xAB4KcO2AX12QhNe5SVKauDaYJ48KGiCSiWFbSQcJX3ugQ9yJxc6ZVOMHT1SrP/zQqN8Vc5OWsJeBevb0qVIEl0ITuaT0uxi1esagsPuem2UkoE7UiKa0iaphmEdUsHE0iOnLJnk2CV4okEfYumwcicEeCcQmCed+CzpaK4iyuggvm4l1q4GrmYcKK5lGCa3+q5SGChhaC1eesPEXClqAtrfkC6lWClKRC7stsHtFsJdUq1uTsIu0sJ4fq7fBC8k6C6xBsIxpu8OrG8zOsvUPe8KBN00qt+a1u9gXS92DsUzru9KtG93msS4Bu+IjG+5OsR5nu+pqO96msT6du+FMG+8PsS7zu/SCu/9vu9+Ju/4ru//Fu+/vu/6BvAAry+BTy6BHzA8avAPVK/DIwN/xAVQQ78wMkgXflKZBSsExeGKROcwSyBOvlKptbwLiRcwiZ8wiicwiq8wizcwi78wjAcwzI8wzSstBXcMh2GXyvcNTTswjzcwyz8w0CswkI8xChcxEZswkicxCVcqCDBomkUvFKcwFOMBsbbwYQAWLQje9sYTlT8xVYMxmdwxQlMCTlsd2JsBlU8xmmsxmWcDGvsxmE8x2ycBljMCXEMOnQsx3W8xydBL2gAyGcgyGZAyGVgyGSAyIlswx7cyI78yJAcyZI8yQ/sUQEgrQAQXKMAiKGQRZncyZ9aBPMSMZa8yZ+MRbAQXJ4sLwYQNMHVDqqcyqAcXcUwV7HMyaiMy/+r3AQ7iUVFEMG6LMu5HDNXhMlCAMyn7Mm3TMyXPASaLMzKPMuxkm+rIDZB6qsAAHK2IATabJdOYADfYA/ZaJfdzM2ssM27Gs5DYMHUZc6tQM7n7M1NUC7+U87ZHM/ujM5OQM/rPA/tYM/23AQ/gwHV3M/nCtD47AQDXdDX/Ar3/M75LM/6sAECEFLzMC/bnAu+dV/fYAEbDQAd/QTkYg8WkAAJAA0G8NEdrdItI9LjYg/kNQQs7dECwNEt7QTrAG0AMNM8XdMgfdNNkNPjMgQbvNM+vdJHDdRLQNEWzYDmDA49bdPGrARMDQAXfWC4kC1R/dNTDQ8ElQu/0ADBwGH/4NBhOXzGToDWQwANslLW3XDWF8wEZ0xf9kXW12DWbn09MlNdcF0Med3X00oP1gTCd/3Xee0EX20uAUDYdm3XgN0EiR1RqyDWwtDXj70Pkd0MzxANln3YT6DWAMANYtPZha07Z3xgCRYKhl3aURDSpO3Ynv0EIb1EFgDYeM3akG0uuUDbtv3Wsb0Eme0MBJcArw3a8BDSq/CK4BDOog0ATN3cVf3ZF0zRIAPdFW3dh5fW57pE1dNh2I3d8tIKn/Pduerc113e0Z0K4m1NUEzeYpPeS4Dcz7c15SIK6H3e713RTiDfyu0N3eDe5p3d+rClvlVd54Bg6rDXDAQxCs7W/7v6McjwDQ3UyvSw4AjQ4Ez0zRAuBC4GYxh+4RXu4AINcvDy4SYe4hnOBNTKCiVOLx8D4gxg4R+O0zVd4ACgxS9+4jEu4kxA4IJ94Kmt4xYOEPJgC8dT5PUgBANHD5+z5AzwZUvAoiNU3wDg5E0ODU8OBVIOAEHmClfO5EqO5VCeBOJl5WEO5lUu5rvKor9yxmae5mjuBEVurezdDm/+5nJel0c+D0kO51nu52NOyYI+6IRe6IZ+6Iie6Iq+6Ize6I7+6JAe6ZLuM1eURQegq0tNc0B2AIEeBT6nopMeCBuzYRuW2+FgLrLCyPcwnKEOCDKDAbqwk0MlQr12ANmtAP9cugGB+FvEnd0I0AojoACpDgDE0GsXQNycLgQIMAIHYDynTgHMLq3Tc+mkQAy0Yu3EoAGhFNpdkzqtrgbN/aXVs9EUPdo17W1R9VsHgAHldWm2sAG1UNgE7QpkxeAEvdhOhy+ukHIXfu8ETda6sDU35M/YsgHrpurf/ktxvWHfQApkZdXVlcm7vjVfJvDE7ta6sGECzw1QhnYWT9EGwA0FRtE7qdjZsjXS+g2DhPAJXwXnsHK0smGtIAQzX+o0Tw9xbfHxDvCzDvBbYzcLo+8Bf/Imf0NDb/SAOAIX1tUtLwbQYA1c2vPccMlJbUNi2goIENPh1A30gvE9L/BL1ACBLrMBJ3rBFg/2Nc1AZcUNDeBtRI8MI2BD8N30Y4AA30APIVXqRX7smewM9PDrv1ULDHAvWZ/2Xq/x5vJiSeRRKc7zFr/kBbfrDfANSM9h84A6dH8KFzB7ma8QF9DFnR/6oj/6pF/6pn/6qJ/6qr/6rN/6rv/6sB/7sj/7tF/7hRAEADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hourly serum testosterone levels in normal young (n = 17) and old (n = 12) men. The circadian rhythm is lost in old men. Blood samples were obtained using an indwelling peripheral venous cannula, which allowed free movement and normal sleep.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Bremner, WJ, Vitiello, MV, Prinz, PN, J Clin Endocrinol Metab 1983; 56:1278.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40365=[""].join("\n");
var outline_f39_26_40365=null;
var title_f39_26_40366="Cebocephaly";
var content_f39_26_40366=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cebocephaly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 268px; height: 373px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The closely approximated nostrils, small mouth, and hypotelorism in this infant are clinical manifestations of holoprosencephaly.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40366=[""].join("\n");
var outline_f39_26_40366=null;
var title_f39_26_40367="IgM deposits in mixed cryo IF";
var content_f39_26_40367=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F60046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F60046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    IgM deposits in mixed cryoglobulinemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunofluorescence microscopy showing almost pathognomonic diffuse deposition of IgM in the capillary loops in mixed cryoglobulinemia. The subendothelial location of these deposits is suggested by the relatively smooth outer portions (arrows) due to their pressing against the inner aspect of the glomerular basement membrane.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_26_40367=[""].join("\n");
var outline_f39_26_40367=null;
